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ABSTRACT
Human body is in continuous contact with microbes. Although many microbes are 
harmless or beneficial for humans, pathogenic microbes possess a threat to 
wellbeing. Antimicrobial protection is provided by the immune system, which can 
be functionally divided into two parts, namely innate and adaptive immunity. The 
key players of the innate immunity are phagocytic white blood cells such as 
neutrophils, monocytes, macrophages and dendritic cells (DCs), which constantly 
monitor the blood and peripheral tissues. These cells are armed for rapid activation 
upon microbial contact since they express a variety of microbe-recognizing 
receptors. Macrophages and DCs also act as antigen presenting cells (APCs) and 
play an important role in the development of adaptive immunity. The development 
of adaptive immunity requires intimate cooperation between APCs and T 
lymphocytes and results in microbe-specific immune responses. Moreover, adaptive 
immunity generates immunological memory, which rapidly and efficiently protects 
the host from reinfection.  
Properly functioning immune system requires efficient communication between 
cells. Cytokines are proteins, which mediate intercellular communication. Immune 
cells produce inflammatory cytokines rapidly following microbial contact. 
Inflammatory cytokines modulate the development of local immune response by 
binding to cell surface receptors, which results in the activation of intracellular 
signalling and modulates target cell gene expression. One class of inflammatory 
cytokines – chemokines – has a major role in regulating cellular traffic. Locally 
produced inflammatory chemokines guide the recruitment of effector cells to the site 
of inflammation during microbial infection.  
In this study two key questions were addressed. First, the ability of pathogenic and 
non-pathogenic Gram-positive bacteria to activate inflammatory cytokine and 
chemokine production in different human APCs was compared. In these studies 
macrophages and DCs were stimulated with pathogenic Steptococcus pyogenes or 
non-pathogenic Lactobacillus rhamnosus. The second aim of this thesis work was to 
analyze the role of pro-inflammatory cytokines in the regulation of microbe-induced 
chemokine production. In these studies bacteria-stimulated macrophages and 
influenza A virus-infected lung epithelial cells were used as model systems. 
The results of this study show that although macrophages and DCs share several 
common antimicrobial functions, these cells have significantly distinct responses 
against pathogenic and non-pathogenic Gram-positive bacteria. Macrophages were 
activated in a nearly similar fashion by pathogenic S. pyogenes and non-pathogenic 
L. rhamnosus. Both bacteria induced the production of similar core set of 
inflammatory chemokines consisting of several CC-class chemokines and CXCL8. 
These chemokines attract monocytes, neutrophils, dendritic cells and T cells. Thus, 
the results suggest that bacteria-activated macrophages efficiently recruit other 
effector cells to the site of inflammation. Moreover, macrophages seem to be 
activated by all bacteria irrespective of their pathogenicity. DCs, in contrast, were 
efficiently activated only by pathogenic S. pyogenes, which induced DC maturation 
and production of several inflammatory cytokines and chemokines. In contrast, L.
rhamnosus-stimulated DCs matured only partially and, most importantly, these cells 
did not produce inflammatory cytokines or chemokines. L. rhamnosus-stimulated 
DCs had a phenotype of "semi-mature" DCs and this type of DCs have been 
suggested to enhance tolerogenic adaptive immune responses. Since DCs have an 
essential role in the development of adaptive immune response the results suggest 
that, in contrast to macrophages, DCs may be able to discriminate between 
pathogenic and non-pathogenic bacteria and thus mount appropriate inflammatory or 
tolerogenic adaptive immune response depending on the microbe in question.  
The results of this study also show that pro-inflammatory cytokines can contribute to 
microbe-induced chemokine production at multiple levels. S. pyogenes-induced type 
I interferon (IFN) was found to enhance the production of certain inflammatory 
chemokines in macrophages during bacterial stimulation. Thus, bacteria-induced 
chemokine production is regulated by direct (microbe-induced) and indirect (pro-
inflammatory cytokine-induced) mechanisms during inflammation. In epithelial 
cells IFN-α and tumor necrosis factor-α were found to enhance the expression of 
microbe-detection receptors and components of cellular signal transduction 
machinery. Pre-treatment of epithelial cells with these cytokines prior to virus 
infection resulted in markedly enhanced chemokine response compared to untreated 
cells. In conclusion, the results obtained from this study show that pro-inflammatory 
cytokines can enhance microbe-induced chemokine production during microbial 
infection by providing a positive feedback loop. In addition, pro-inflammatory 
cytokines can render normally low-responding cells to high chemokine producers 
via enhancement of microbial detection and signal transduction.  
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TIIVISTELMÄ 
Immuunijärjestelmä suojaa elimistöä taudinauheuttajamikrobeilta ja pahanlaatuisilta 
solumuutoksilta. Elimistön mikrobipuolustukseen osallistuvat seerumin 
antimikrobiset proteiinit ja erityisesti veren valkosolut. Veren ja kudosten 
neutrofiilit, monosyytit, makrofagit, sekä dendriittisolut tarkkailevat ympäristöään 
mikrobien ja muiden taudinaiheuttajien varalta. Nämä valkosolutyypit ilmentävät 
lukuisia mikrobireseptoreja, joiden avulla ne tunnistavat mikrobirakenteita, kuten 
bakteerien pinnan lipopolysakkarideja, peptidoglykaania tai virusten kaksijuosteista 
RNA:ta. Tunnistustapahtuma käynnistää solunsisäisen signaalinvälityksen, mikä 
johtaa valkosolujen geeniluennan ja sitä kautta toiminnan muutoksiin. 
Valkosoluaktivaation tavoittena on pysäyttää infektion leviäminen mahdollisimman 
nopeasti. 
Solujen välinen viestintä on ehdoton edellytys toimivalle immuunijärjestelmälle. 
Liukoiset sytokiiniproteiinit ovat yksi tärkeimmistä immuunivasteen 
välittäjäaineista. Sytokiinigeenien luenta käynnistyy nopeasti mikrobikohtaamisen 
seurauksena. Nämä tulehdustyyppiset sytokiinit, eli pro-inflammatoriset sytokiinit, 
säätelevät immunivasteen kehittymistä mm. aktivoiden antimikrobisten tekijöiden 
tuotantoa. Eräs sytokiiniryhmä – kemokiinit - säätelee valkosoluliikennettä 
tulehdusalueella.  
Tässä työssä on vertailtu patogeenisen Streptococcus pyogenes ja ei-patogeenisen 
Lactobacillus rhamnosus-bakteerin kykyä aktivoida ihmisen valkosoluja. Tulokset 
osoittavat, että S. pyogenes aktivoi inflammatorisen välittäjäainevasteen 
makrofageissa ja kaikissa tutkituissa dendriittisolutyypeissä. Ihmisen immuunivaste 
näyttää siis aktivoituvan tehokkaasti S. pyogenes-bakteeria vastaan, mikä osaltaan 
johtaa tämän bakteerin tuhoamiseen ja infektion leviämisen estämiseen. Toisaalta 
voimakas välittäjäainetuotanto ja siitä mahdollisesti seuraava ylisuuri 
immuunivasteen aktivaatio saattaa pahimmillaan johtaa kudostuhoon tai 
streptokokki-infektion jälkitauteina kehittyviin autoimmuunitauteihin. Ei-
patogeeninen, elimistön normaaliflooraan kuuluva maitohappobakteeri L. 
rhamnosus aktivoi makrofagit ja dendriittisolut vain osittain eikä saanut aikaan 
inflammatoristen välittäjäaineiden tuotantoa dendriittisoluista. Inflammatorisen 
vasteen puuttuminen voi osaltaan selittää elimistön ja sen normaalimikrobiston 
välistä toleranssia ja symbioottista vuorovaikutusta.  
Tässä työssä on lisäksi selvitetty pro-inflammatoristen sytokiinien vaikutuksia 
solujen välittäjäaineiden tuotantoon bakteeri- ja virusinfektiossa. Tulokset 
osoittavat, että infektion aikana tuotettavat pro-inflammatoriset sytokiinit, erityisesti 
interferoni (IFN)-α, lisäävät patogeenisen S. pyogenes-bakteerin aikaansaamaa 
välittäjäainetuotantoa, mikä edelleen tehostaa immuunivasteen aktivaatiota. IFN-α:n
ja tuumorinekroositekijä-α:n osoitettiin myös lisäävän solujen 
mikrobitunnistusreseptorien ja signaalinvälityskomponenttien ilmentymistä, minkä 
seurauksena epiteelisolujen virusvaste tehostui merkittävästi. Tulokset osoittavat, 
että tehokas immuunivasteen aktivaatio riippuu sekä suorista mikrobi-kohdesolu 
vuorovaikutuksista että infektion aikana tuotettavien sytokiinien välittämistä 
signaaleista.  
Avainsanat: immuunijärjestelmä, välittäjäaine, geenisäätely, bakteeri, influenssa A virus 
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ABBREVIATIONS 
APC antigen presenting cell 
CARD caspase recruitment domain 
CD cluster of differentiation 
CTL cytotoxic T lymphocyte 
DC dendritic cell 
DC-SIGN DC-specific ICAM3-grabbing non-integrin 
dsRNA double stranded RNA 
ELISA enzyme-linked immunosorbent assay 
FCS fetal calf serum 
GAS interferon gamma-activated sequence element 
GM-CSF granulocyte-macrophage colony stimulating factor 
IFN interferon 
IKK inhibitory κB kinase 
IL interleukin 
Ipaf ICE protease-activating factor 
IRAK IL-1 receptor associated kinase 
IRF interferon regulatory factor 
ISGF interferon stimulated gene factor 
ISRE interferon-stimulated response element 
Jak Janus tyrosine kinase 
LPS lipopolysaccharide 
LRR leucine-rich repeat 
LTA lipoteichoic acid 
MAPK mitogen-activated protein kinase 
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MARCO macrophage receptor with collagenous structure 
mDC myeloid dendritic cell 
MHC major histocompatibility complex 
mo-DC monocyte-derived dendritic cell 
mRNA messenger RNA 
MyD myeloid differentiation factor 
NF-κB nuclear factor kappa-B 
NK natural killer cell 
NLR NOD-like receptor 
NOD nucleotide-binding oligomerization domain 
PAMP pathogen associated molecular pattern 
PBMC peripheral blood mononuclear cell 
PBS phosphate buffered saline 
pDC plasmacytoid dendritic cell 
PGN peptidoglycan 
PRR pattern recognition receptor 
RIG-I retinoid acid-inducible gene I 
RIP receptor interacting protein 
rRNA ribosomal RNA 
SARM Sterile alpha and HEAT/Armadillo motif protein 
SR scavenger receptor 
STAT signal transducer and activator of transcription 
TBK Tank binding kinase 
TCR T cell receptor 
TGF transforming growth factor 
Th T helper cell 
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TIR Toll/IL-1 receptor  
TIRAP TIR domain containing adaptor 
TLR Toll-like receptor 
TNF tumor necrosis factor 
TRAF TNF receptor-associated factor 
TRAM TRIF-related adaptor molecule 
TRIF TIR domain-containing adaptor inducing IFN-β  
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1 INTRODUCTION
Human body is in continuous contact with microbes. Although many microbes are 
beneficial or harmless to humans, pathogenic microbes are a threat and can cause 
severe infections. Mechanical shield against microbial invasion is provided by rigid 
skin and sticky mucosal surfaces. Moreover, secreted antimicrobial compounds, 
enzymes and low pH offer further protection at these sites. However, these primary 
defence systems are often inadequate as, during the course of evolution, pathogenic 
microbes have developed means to overcome these barriers and invade. More 
efficient and powerful antimicrobial defence is provided by the immune system, 
which can be functionally divided into two parts. The innate immunity acts rapidly 
and non-specifically towards foreign components. Adaptive immunity, on the other 
hand, requires time to develop but it is specific to foreign antigens and generates 
immunological memory.  
The non-specific innate immunity requires coordinated action of several effector 
cells and serum proteins. Bacterial infections are controlled by phagocytic 
neutrophils, monocyte/macrophages and dendritic cells, which constantly patrol in 
blood and tissues and are ready to engulf and destroy microbes. The innate immune 
defence against intracellular bacteria or viruses, which generally can not be detected 
by phagocytes, is controlled by natural killer (NK) cells, which detect and destroy 
infected cells. Recognition and uptake of microbes is based on germ line-encoded 
pattern recognition receptors (PRRs). These receptors detect conserved microbial 
structures that are not found in the host. The innate antimicrobial defence is 
significantly assisted by several serum proteins which detect and bind to microbes 
thereby promoting the uptake and destruction of microbes by immune cells. A 
common aim of the innate immunity is to rapidly detect and stop the spread of a 
pathogen. Several components of the human innate immunity have an evolutionarily 
ancient background and can be found in invertebrates. 
In contrast to the innate immunity, adaptive or acquired immunity is specific to 
foreign antigens. Adaptive immunity offers pathogen-specific detection and targeted 
immune response, which is usually effective also against those microbes that may 
evade innate immune responses. Moreover, the immunological memory offers rapid, 
specific and efficient immune response upon reinfection. The development of 
adaptive immunity requires a complex co-operation between antigen presenting cells 
(APCs) (macrophages, dendritic cells, and B cells) and T lymphocytes.  
The key factor of a functional immune system is an effective communication 
between different cells. Cytokines are secretory proteins that act as messengers 
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between cells. Cytokines are involved in practically all steps of the immune 
response by regulating homeostasis as well as inflammatory responses. One class of 
cytokines - chemokines - has an essential role in regulating the traffic of immune 
cells. Inflammatory cytokines and chemokines are produced at the early times of 
microbial infection. The local production of these mediators regulates the 
development of immune response by recruiting cells to the site of inflammation and 
by modulating the gene expression of effector cells.   
In the present work two key questions were addressed. First, the inflammatory 
cytokine and chemokine response induced by pathogenic and non-pathogenic Gram-
positive bacteria was compared in human macrophages and dendritic cells. 
Secondly, the role of pro-inflammatory cytokines in the regulation of microbe-
induced chemokine gene expression was evaluated in bacteria-stimulated 
macrophages and virus-infected epithelial cells.  
17
2 REVIEW OF THE LITERATURE 
2.1 Effector cells of the immune response 
Macrophages and dendritic cells patrol in blood and other tissues and these cells 
are armed to detect and destroy microbes. An important feature, which distinguishes 
macrophages and dendritic cells from other phagocytes, is that they are able to 
process exo- or endogenous antigens and present them to T cells in the context of 
cell surface major histocompatibility complex (MHC) molecules. Thus, while 
phagocytic neutrophils primarily act as innate immune cells, macrophages and 
dendritic cells are also able to initiate adaptive immune responses.  
2.1.1 Macrophages
The cells of monocyte/macrophage lineage develop in the bone-marrow from 
common myeloid progenitor cells. The same myeloid progenitor gives rise to 
granulocytes, megakaryocytes and erythrocytes. Differentiated monocytes are 
released from the bone-marrow into blood and in a couple of days they enter tissues 
and differentiate into macrophages. (Reviewed in 44) Macrophages show 
remarkable diversity in their phenotype and function depending on their anatomical 
location. Macrophage differentiation and functional specialization is dependent on 
the tissue microenvironment, which consists of growth factors, cytokines and other 
cell types present (44). Different macrophage types are involved in various 
biological processes ranging from tissue/bone remodeling and wound healing to 
anti-microbial immune defence (173). Macrophages have three major functions in 
anti-microbial response. They phagocytose and destroy microbes, produce large 
amounts of cytokines and chemokines and act as antigen presenting cells. 
The first step in antimicrobial defence is to detect foreign structures and distinguish 
them from the self. For these purposes macrophages express multiple pattern 
recognition receptors (PRRs) which detect conserved structures found in microbes 
but that are absent from host cells. Macrophages can phagocytose extracellular 
microbes by using several receptor systems. Scavenger receptors (SRs), such as SR-
A, CD36 and macrophage receptor with collagenous structure (MARCO), in 
addition to lectin-type receptors, detect and bind microbial surface structures, which 
leads to the uptake of the microbe (185). Microbes coated with serum complement 
proteins or antibodies are phagocytosed via cell surface complement and Fcγ
receptors, respectively (185). Microbe-induced macrophage gene expression is 
induced primarily via Toll-like receptors (TLRs) and nucleotide-binding 
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oligomerization domain-like receptors (NLRs). These receptors detect a variety of 
bacterial and viral structures including lipopolysaccharide (LPS), peptidoglycan 
(PGN) or viral RNA (2, 188). Macrophages are equipped with a broad set of TLRs 
and NLRs in order to rapidly detect and respond to a variety of microbes. 
Macrophages kill microbes by fusing the microbe-containing phagosomes with 
lysosomes, which contain proteolytic enzymes. Moreover, activated macrophages 
produce reactive oxygen and nitrogen intermediates, which further enhance the 
destruction of the engulfed microbes. Although microbial killing is usually efficient, 
some intracellular bacteria, including Listeria monocytogenes, Salmonella 
typhimurium and Mycobacterium tuberculosis are able to disrupt the phagolysosome 
fusion and persist inside macrophages.  
Another key feature of activated macrophages is the production of cytokines and 
chemokines, which enhances local antimicrobial defence systems. Activated 
macrophages produce tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6, 
interferons (IFNs) and a multitude of CC and CXC chemokines. Moreover, 
depending on the stimulus, several T cell activating cytokines such as IL-12, IL-18, 
IL-23 and IL-27 are produced (1, 125, 173). Local cytokine environment also 
modulates the nature and extent of macrophage activation. Classical macrophage 
activators IFN-γ and TNF-α enhance the production of reactive nitrogen and oxygen 
intermediates, pro-inflammatory cytokines, and Th1 polarizing cytokines (43, 173). 
In contrast, IL-4, IL-13 or glucocorticoids reduce the pro-inflammatory response and 
promote the production of IL-10 and other anti-inflammatory mediators (43, 98, 
173). Downregulation of the inflammatory response is important to avoid excess 
damage to the host and to restore homeostasis after inflammation. 
Microbe-induced macrophage activation increases the expression of cell surface 
MHC and T cell co-stimulatory molecules. This enhances the ability of macrophages 
to present antigens to T cells. Macrophages are, however, inefficient in priming 
naïve T cells and their role is more likely to initiate recall responses to previously 
encountered antigens. (Reviewed in 6, 145)  
2.1.2 Dendritic cells 
Macrophages and dendritic cells (DCs) share several functions in the antimicrobial 
defence. Both cell types rapidly recognize microbes, produce cytokines and 
chemokines and act as APCs. However, DCs are unique APCs in the sense that only 
DCs are able to activate naïve T cells and thereby initiate de novo adaptive immune 
responses (6, 145). Humans have several specialized DC types including myeloid 
DCs (mDC), plasmacytoid DCs (pDC) and skin-specific Langerhans cells.  
19
Human mDC and pDCs have both phenotypic and functional differences as they 
express different PRRs and produce partially distinct set of cytokines. More 
specifically, mDCs express TLR1, 2, 3, 4, 5, 6, 8, and 10, while pDCs express 
TLR1, 6, 7, and 9 (63, 74, 92). Thus, pDCs and mDCs respond to different microbes 
and/or microbial structural components. A specific feature of pDCs is their capacity 
to produce vast amounts of type I IFNs compared to other cell types (21, 93). In 
contrast, mDCs produce IL-12 and IL-10, which human pDCs do not produce (93). 
mDCs and pDCs can be isolated directly from human blood. These circulating DCs 
are scarce and typically represent only 0,5-2% of peripheral blood mononuclear cells 
(PBMCs). Thus, most human DC studies have been performed with monocyte-
derived DCs (mo-DCs), which can be generated by culturing monocytes in the 
presence of granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-4 
(153). There is some controversy whether human monocytes differentiate into mo-
DCs in vivo. However, by using an in vitro culturing system, monocytes traversing 
endothelial cell layer have been shown to adopt DC properties (143). The gene 
expression pattern and functions of mo-DCs resemble those of blood-derived mDCs 
closely but not completely (72, 96).  
DCs patrol in blood and tissues in an immature state and constantly monitor the 
periphery by capturing antigens via phagocytosis, endocytosis and pinocytosis (6). 
DCs can also capture microbes by engulfing infected dying cells or by penetrating 
their dendrites through tight junctions of epithelial cells. A contact with a microbe or 
another antigen activates a DC maturation process, which results in several drastic 
changes in DC phenotype and function. During maturation the endocytotic activity 
of DCs decreases and antigen processing is initiated (6). Moreover, the expression of 
cell surface MHC and CD80 and CD86 co-stimulatory molecules is enhanced (6). 
Microbe-activated DCs also produce a variety pro-inflammatory and T cell 
activating cytokines and chemokines during maturation. Depending on the activation 
stimulus DCs can produce Th1 polarizing IL-12 family cytokines or tolerance 
inducing IL-10 (65, 95, 172). It was also recently reported that maturing DCs 
produce IL-2, which enhances DC-mediated T and NK cell activation (45, 46, 48). 
One key mechanism rendering DCs so efficient APCs is that mature DCs are able to 
leave the periphery and home to local lymph nodes, where antigen presentation to T 
cells takes place. The lymph node homing is mediated by a change in the DC 
chemokine receptor expression during maturation. Maturing DCs start to express 
CCR7 and thus DCs become sensitive to CCL19 and CCL21 chemokines which are 
produced in lymphatic vessels (155, 156).   
Although the role of DCs in initiating adaptive immune responses against pathogens 
has been known for long, it is becoming evident that DCs have a significant role also 
in maintaining peripheral tolerance and homeostasis. The activation state of DCs 
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seems to play a significant role in this process. Tolerogenic DCs are generated under 
steady-state (non-inflammatory) conditions, i.e. when DCs ingest apoptotic cells in 
the absence of inflammation (172). Tolerogenic DCs have been shown to promote 
deletion or anergy of autoreactive peripheral T cells which may have escaped the 
normal thymic selection (central tolerance).  A general feature of tolerogenic DCs is 
that they express T cell co-stimulatory molecules on the cell surface but they do not 
produce inflammatory cytokines (145, 152, 172). 
2.1.3 From innate to adaptive immunity 
The function of the innate immunity is to rapidly detect invading microbes and to 
stop or at least limit the infection. This also gives time for the development of 
adaptive immunity. Adaptive immunity is antigen-specific and thus offers a more 
precise and efficient recognition of microbes or their structural components as 
compared to innate immunity. Most importantly, adaptive immunity generates 
immunological memory, which enables rapid immune activation upon reinfection. 
The development of adaptive immunity requires an intimate interplay between APCs 
and T and B lymphocytes. The main function of B cells is to produce antibodies 
which protect the host from extracellular microbes and parasites. Upon reinfection 
memory B cells and circulating serum antibodies rapidly recognize invading 
pathogens and initiate the activation of immune response. Cytotoxic CD8+ T cells 
(CTLs) control intracellular pathogens by destroying infected cells via the release of 
intracellular cytotoxic molecules such as perforin. Both B cells and CTLs require 
activating signals from CD4+ T helper (Th) cells. The polarization of CD4+ Th cells 
determines whether adaptive immune response is Th1 type (CTLs) or Th2 type (B 
cells). This classical Th1/Th2 paradigm has been recently updated after additional 
effector T cell types have been identified. IL-17 producing Th17 cells play a central 
role in the pathology of inflammatory autoimmune diseases (79). These cells may 
also mediate host response against certain pathogens (54, 79). Moreover, at least 
three regulatory T cell types have been characterized. Regulatory T cells are 
important in maintaining peripheral tolerance and limiting extensive immune 
response via direct cell-cell contacts and/or by the production of suppressive 
cytokines IL-10 and transforming growth factor (TGF)-β (116, 172). 
The activation and polarization of naïve Th0 cells requires three signals from APCs. 
The first signal consists of processed microbe-derived peptides, which are presented 
to T cells in the context of APC MHC molecules. The peptide-MHC complex is 
recognized by cognate T cell receptor (TCR) on T cell surface. The second signal is 
delivered by co-stimulatory molecules such as CD80 and CD86 which are 
recognized by T cell CD28 receptor. Co-stimulation is important as it activates 
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intracellular signalling in both APCs and T cells. The third signal determines the 
polarization of Th0 cells. Soluble APC-derived cytokines and several cell surface 
receptors transfer the polarization signals to T cells. The classical Th1 polarization 
factors include type I and II IFNs, IL-12, IL-18 and IL-27 (65, 177). Th17 
polarization is mediated by TGF-β, IL-6 and IL-23 (65, 79, 195). The mediators of 
Th2 polarization are still somewhat ill defined but the lack of Th1 polarizing 
cytokines, expression of IL-4, prostaglandin E2 (PGE2), or histamine and cell 
surface OX40-OX40L receptor pair plays a role here  (27, 50, 76). Cytokine-
mediated signalling in antigen presentation is not unidirectional. For example T cell-
derived IFN-γ enhances APC activation while IL-10, IL-21 or TGF-β can 
downmodulate APC functions and promote homeostasis. To sum up, a complex 
network involving both cell-cell contacts and soluble mediators determines the 
development of adaptive immune response. 
2.2 Microbe recognition by the innate immune system
In order to discriminate harmful pathogens from “self” the immune system utilizes 
PRRs. PRRs detect conserved structures that are found in microbes but are absent 
from the host (71). Such structures are called pathogen associated microbial patterns 
(PAMPs) and they include i.e. bacterial lipopolysaccharide (LPS), peptidoglycan 
(PGN) and unmethylated CpG-rich DNA (2, 188). A general property of PAMPs is 
that they are structurally versatile and include lipids, proteins, carbohydrates and 
nucleic acids. PRRs can be classified into families based on the domains the 
receptors have. The most common are lectin, cysteine-rich and leucine-rich repeat 
domains (107). The main functions of PRRs include the activation of complement 
cascade, enhancement of phagocytosis and initiation of intracellular signalling and 
gene expression. 
In a broad sense many serum proteins including certain complement proteins, 
mannan binding lectin (MBL), C-reactive protein (CRP) and serum amyloid P-
protein (SAP) can be classified as PRRs. These proteins bind to microbial surface 
proteins, carbohydrates or lipid structures. Serum factors initiate complement-
mediated microbial lysis and promote phagocytosis of microbes. Reviewed in (71, 
107)  
Professional immune cells express a variety of PRRs on their cell surfaces and 
intracellular compartments. Scavenger receptor family includes several structurally 
unrelated cell surface receptors that mediate phagocytosis of bacteria. For example, 
type I and II scavenger receptor A (SR-AI/II) binds LPS and lipoteichoic acid (LTA) 
and enhances the uptake of Escherichia coli and Staphylococcus aureus by 
macrophages (30, 52, 139). In vivo experiments performed with SR-AI/II knockout 
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mice have demonstrated that these mice are more susceptible to S. aureus infection 
compared to wild type mice (186). Other scavenger receptors, such as MARCO, 
CD36 and lectin-like oxidized low density lipoprotein receptor (LOX)-1 bind both 
Gram-negative and Gram-positive bacteria (32, 33, 163, 175). Another family of 
phagocytosis receptors is C-type lectins. Several C-type lectin receptors have been 
cloned but the specific microbial ligands have remained largely uncharacterized. 
Most information is available on macrophage mannose receptor (MMR), which 
detects mannose and fucose residues on microbial surfaces (185). The DC-restricted 
receptor dendritic-cell-specific ICAM3-grabbing non-integrin (DC-SIGN) binds 
mannan, mannosyl-lipoarabinomannan and modified Lewis blood group antigens 
and this receptor has been shown to mediate the uptake of mycobacteria and HIV by 
DCs (13). Dectin-1 receptor is expressed on macrophages and DCs and this receptor 
detects β-glucan structures found in yeast cell wall (13, 185).  
The above discussed PRRs have traditionally been thought to mediate microbial 
detection and phagocytosis but not the activation of gene expression. The discovery 
of TLRs and later on NLRs and caspase recruitment domain (CARD)-helicase 
receptors has integrated microbial recognition to the activation of intracellular signal 
transduction and gene expression. The distinction between signalling and 
phagocytosis receptors is, however, likely to change as recent reports have 
demonstrated that engagement of Dectin-1 and DC-SIGN activates intracellular 
signalling and cytokine production (14, 148, 189).  
2.2.1 Toll-like receptors 
The involvement of TLRs in innate immunity was first demonstrated in Drosophila 
where TLRs were found to be essential for anti-fungal and anti-bacterial defence 
(88, 197). Subsequently, TLR homologs were described in humans (108, 146). 
Currently 12 mammalian TLRs have been identified (2, 188). TLRs are most 
prominently expressed by professional antigen presenting cells including 
macrophages and dendritic cells. In contrast, TLRs are usually expressed at low or 
undetectable levels by epithelial or endothelial cells. Inflammatory signals, such as 
cytokines or microbial attack can, however, enhance TLR expression also in non-
immune cells (2). TLRs are germ line-encoded type I integral membrane 
glycoproteins. The extracellular domain of TLRs contains a leucine-rich repeat 
(LRR) motif, which mediates PAMP detection. The cytoplasmic signalling domain 
of TLRs is homologous to interleukin 1 receptor and thus named Toll/IL-1R (TIR) 
domain. The intracellular domain is essential for the activation of intracellular 
signalling.
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The first TLR ligand described was bacterial LPS, which is detected by TLR4 (142). 
In recent years the ligands for several but not all TLRs have been identified 
(summarized in Table 1). Significant variability in the structures of TLR ligands 
exists and they can consist of lipids, proteins or nucleic acids. Interestingly, some 
TLRs can detect ligands from several of these categories (2). Further fine-tuning on 
the ligand specificity is achieved by formation of TLR heterodimers. For example 
the TLR1/TLR2 dimer detects bacterial triacyl lipopeptides, while TLR2/TLR6 
recognizes diacyl lipopeptide structures (183). At least some TLRs require accessory 
molecules for PAMP detection. For example TLR4 requires MD2, CD14 and LPS-
binding protein (LBP) for efficient signal transduction, while CD36 mediates the 
detection of diacylglyserols by TLR2/TLR6 dimer (59, 73, 142, 164). The cellular 
location of TLRs varies. TLRs 1, 2, 4, 5 and 6 are expressed on the cell surface 
while TLRs 3, 7, 8 and 9 are found intracellularly in endosomes (2, 182). 
Intracellular TLRs detect nucleic acids which are also produced by the host. Thus, it 
is likely that the endosomal location of these TLRs prevents uncontrolled immune 
activation by endogenous nucleic acids.  
TLR signalling is initiated by ligand binding, which results in the dimerization or 
multimerization of TLRs. Subsequently, TIR-domain-containing adaptor molecules 
are recruited to the intracellular domain of TLRs. Five adaptor molecules have been 
identified. These include myeloid differentiation factor 88 (MyD88), TIR-domain-
containing adaptor inducing IFN-β (TRIF), TIR-domain containing adaptor protein 
(TIRAP), TRIF-related adaptor molecule (TRAM) and Sterile alpha and 
HEAT/Armadillo motif protein (SARM). The key players here are MyD88 and 
TRIF, which mediate the activation of downstream signalling (2). MyD88 is used by 
all TLRs except TLR3, while TRIF signalling is used by TLR3 and TLR4. 
TIRAP/MAL is required for interaction of MyD88 with TLR2 and TLR4, while 
TRAM enables TLR4-TRIF interaction (2, 134). The fifth adaptor protein SARM 
was recently shown to negatively regulate TRIF signalling (15). Downstream TLR 
signalling includes several phosphorylation and ubiquitination steps where TNF 
receptor associated factor (TRAF) proteins and interleukin-1 receptor associated 
kinases (IRAKs) together with cellular ubiquitination machinery play a key role (2, 
19). Ultimately, TLR signalling results in the activation and nuclear translocation of 
nuclear factor kappaB (NF-κB), interferon regulatory factors (IRFs) and mitogen-
activated protein kinase (MAPK)-regulated transcription factors. These transcription 
factors regulate the expression of a vast majority of anti-microbial genes including 
pro-inflammatory cytokines, chemokines and IFNs. 
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Table 1. Microbial ligands of human TLRs 
Receptor Ligand  Origin of ligand 
TLR1+TLR2 Triacyl lipopeptides Bacteria and mycobacteria 
(Peptidoglycan)  Gram-positive bacteria 
Porins Neisseria
Lipoarabinomannan Mycobacteria 
Phospholipomannan Candida albicans 
Glucuronoxylomannan Cryptococcus neoformans 
Hemagglutin protein Measles virus 
Not known HSV1, HMCV 
TLR2
tGPI-mutin Trypanosoma 
TLR3 dsRNA RNA viruses 
LPS Gram-negative bacteria 
Mannan Candida albicans 
Glucuronoxylomannan Cryptococcus neoformans 
Envelope proteins RSV 
HSP60, 70 Host 
TLR4
Fibrinogen Host 
TLR5 Flagellin Flagellated bacteria 
Lipoteichoic acid Group B Streptococcus
Diacyl lipopeptides Mycoplasma 
TLR2+TLR6 
Zymosan  Saccharomyces cerevisiae 
TLR7/8 ssRNA Viruses 
TLR9 CpG-DNA Bacteria, mycobacteria and viruses 
Adapted from (2, 188) 
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2.2.2 Cytoplasmic sensors 
In addition to TLRs, two cytoplasmic PRR families have been recently described, 
namely nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) 
and caspase-recruitment domain (CARD)-helicase proteins.  
NLRs are expressed in APCs and epithelial cells. It has been suggested that NLRs 
may be especially important in intestinal epithelial cells which are mostly devoid of 
TLRs in order to prevent continuous inflammation. Moreover, NLRs are likely to 
play a role in the detection of certain intracellular bacteria that may escape from the 
phagosomes to the cytoplasm. Two key functions for NLRs have been 
demonstrated. Some NLRs mediate the activation of intracellular signalling 
pathways, while others activate caspase proteases. Reviewed in (24, 103).  
Similar to TLRs, NLRs contain a C-terminal LRR-domain, which is involved in 
ligand sensing. The N-terminal part of NLRs mediates protein-protein interactions 
and signalling. The N-terminus can contain a pyrin domain (PYD), CARD, or 
baculovirus inhibitor of apoptosis repeat (BIR) domain (24, 103). Over 20 NLRs 
have been identified in the human genome but the function or the specific ligand has 
been identified only for few of them. Most information is available on NOD1 and 
NOD2 receptors. NOD1 detects meso-diaminopimelic acid which is a part of Gram-
negative peptidoglycan (17, 40). The ligand for NOD2 is muramyl dipeptide found 
in both Gram-negative and Gram-positive bacteria (41, 68). NOD1 and NOD2 are 
the only NLRs that have thus far been shown to induce intracellular signalling. 
These receptors activate NF-κB and MAPK signalling in receptor-interacting protein 
(RIP)2-dependent fashion (67, 81). In monocytes and DCs NOD1/2 ligands alone 
are relatively weak activators of pro-inflammatory responses but they can act in 
synergy with TLR ligands thus enhancing the inflammatory cytokine response (37, 
179). NOD2 ligands have, however, also been shown to reduce TLR-induced IL-12 
production (193, 194) suggesting that the interactions between TLR and NLR 
pathways may vary considerably depending on cell type, activating stimulus or the 
target gene. Interestingly, frameshift mutations in NOD2 gene are associated with 
increased incidence of Crohn´s disease (102). The mechanisms of how defects in 
NOD2 protein result in the ongoing intestinal inflammation are still uncertain but the 
enhanced production of IL-12 and resulting Th1 polarization may play a key role 
(194). Moreover, defective NOD2-proteins have been shown to reduce the 
production of intestinal antimicrobial peptides which probably weakens the 
clearance of pathogenic microbes and may render host more susceptible to intestinal 
inflammation (81).  
Another key feature of certain NLRs is their ability to activate caspases, which are 
crucial for the posttranslational processing and activation of IL-1β and IL-18 
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cytokines. Caspases also mediate cellular apoptosis. Microbe-induced NLR 
activation may therefore play a key role in the production certain inflammatory 
mediators and, on the other hand, regulate controlled cell death during the microbial 
attack. Thus far the ability to activate caspase-1 has been shown for two NLRs, 
namely Cryopyrin and ICE protease-activating factor (Ipaf) (36). Cryopyrin is 
activated by bacterial RNA, certain antiviral compounds, toxins and endogenous 
uric acid crystals while Ipaf detects bacterial flagellin (75, 99, 101, 110, 176).  
The most recently identified PRR family is the CARD-helicase family which has 
three members; retinoid acid inducible gene-I (RIG-I), melanoma differentiation 
associated gene-5 (mda5) and LGP2 (3, 151, 202). CARD-helicases are intracellular 
sensors of viral dsRNA. The helicase domain of these receptors binds dsRNA while 
the N-terminal CARD domain is responsible for protein-protein interactions and 
signalling. LGP2 lacks the N-terminal CARD domain and this protein has been 
suggested to be a negative regulator of RIG-I and mda5 (151). Activated CARD-
helicases interact with IFN-β promoter-stimulating protein (IPS)-1 adaptor protein. 
The following downstream signalling cascade converges with the TLR signalling 
and results in the activation of NF-κB and IRF transcription factors.  
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Figure 1. Schematic view of microbe detection and signal transduction via pattern 
recognition receptors (PRRs). Toll-like receptors (TLRs) can be expressed 
on cell surface or in intracellular endosomes. Ligand binding to TLR 
recruits adaptor molecules and initiates multistep signal transduction, which 
involves phosphorylation and/or ubiquitination of transcription factors. 
Depending on TLR in question, NF-κB, MAPK and/or IRF signal 
transduction pathways can be activated. Cytoplasmic microbial sensors 
include nucleotide-binding oligomerization domain like receptors (NLRs) 
and caspase-recruitment domain (CARD)-helicases. Certain NLRs, such as 
NOD2, induce NF-κB activation while Ipaf mediates caspase-1 activation 
and proteolytic processing of cytokines instead. CARD-helicases, including 
RIG-I, detect viral dsRNA and activate NF-κB and IRF signal transduction 
pathways. Receptors are coloured blue and adaptor proteins in red. Signal 
transduction components are marked green and transcription factors grey. 
Ligands for each receptor are indicated.  
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2.3 Cytokines
In multicellular organisms effective means to control the interactions between 
different cells are required. Cytokines are soluble polypeptides which act as 
messengers between cells and contribute to nearly all steps of the immune response. 
Cytokines regulate the proliferation, differentiation, and recruitment of cells to 
appropriate location during homeostasis and inflammation. Cytokines regulate target 
cell functions by binding to their specific cell surface receptors, which initiate 
intracellular signalling pathways and gene expression. A general feature of 
cytokines is their pleitoropic and redundant effects. Thus, several cytokines may 
have similar or overlapping functions and compensate each others functions. 
Moreover, different cytokines can also act together and synergistically modulate 
target cell functions. Cytokines are produced locally which distinguishes them from 
hormones, which have more systemic effects. Cytokines are grouped into families 
based on their structural and/or functional similarities. However, for some cytokines 
the structural relationship is less evident and the classification is based mainly on 
proposed tertiary structure and spatial organisation. Cytokine families are 
summarized in Table 2. 
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Table 2. Cytokine families 
Cytokine family Members Biological activities 
Interleukins IL-1 - IL-33 Regulation of cell  
proliferation and 
differentiation, immune cell 
activation/repression 
Interferons IFN-α,β,γ,λ,ω,τ Antiviral, anti-proliferative, 
immunomodulation 
Tumor necrosis factors TNF-α, TNF-β Proinflammatory, apoptosis 
Transforming growth 
factor-β
TGF-β, inhibins, 
activins, bone 
morphogenetic proteins 
Immunomodulation, 
development, 
morphogenesis 
Chemokines C, CC, CXC, CX3C 
type chemokines 
Leukocyte chemotaxis, 
angiogenesis/ angiostasis, 
tumor metastasis, HIV 
infection, polarization of 
adaptive immune response 
Colony stimulating factors GM-CSF, G-CSF, M-
CSF, IL-3 
Growth and differentiation 
of hematopoietic cells 
Growth factors EPO, TPO, EGF, FGF, 
PDGF
Growth and differentiation 
of cells 
Adapted from (196) 
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2.3.1 Inflammatory cytokines 
Inflammatory cytokines are produced at the first wave of microbe-induced stress. 
Common to these cytokines is that they are produced by nearly all cell types and that 
they promote the activation of anti-microbial immune defence systems. The classical 
pro-inflammatory cytokines include TNF-α, IL-1α/β, IL-6 and Type I IFNs. These 
cytokines act on leukocytes as well as on cells of non-immune origin. Professional 
immune cells, especially the cells of monocyte/macrophage/DC lineage also produce 
cytokines able to activate adaptive immune response. The key cytokines regulating 
Th1 polarization are IFNs, IL-12 and IL-27 (65, 177). In contrast, IL-10 and TGF-β
downregulate inflammatory response and enhance the generation of regulatory T 
cells (49, 116). The major characteristics of the inflammatory cytokines analyzed in 
this thesis work are described below.  
Tumor necrosis factor-α
TNF-α is a multifunctional pro-inflammatory cytokine. Environmental stress, such 
as bacterial or virus infection, components of complement cascade, oxygen radicals or 
radiation can induce TNF-α production (192). TNF-α is produced in high levels by 
professional immune cells but it is also inducible in non-immune cells such as 
epithelial cells and fibroblasts. TNF-α is a very potent immune activator and its 
production is tightly controlled.  TNF-α gene expression is mediated by p38 and c-jun 
NH2-terminal kinase (JNK) MAP kinases, which activate the downstream signalling 
molecules activating transcription factor (ATF)-1, ATF-2, ETS-like kinase protein 
(Elk)-1, c-jun and possibly also NF-κB (192, 204). TNF-α production is also regulated 
post-translationally by the cleavage of pro-TNF-α polypeptide into its mature form. 
Binding of TNF-α to its cell surface receptor activates MAPK and NF-κB
transcription factors, which regulate the gene expression of several PRRs, transcription 
factors, cytokines and anti-microbial mediators (192). Additionally, the intracellular 
death domain of TNF-α receptor may trigger caspase activation and apoptosis upon 
TNF-α binding (86). Uncontrolled production of TNF-α is involved in several human 
inflammatory diseases such as Crohn´s disease, arthritis and sepsis.  
Interferons
Interferons were initially described as agents that are able to inhibit virus replication. 
Later on several other important immunomodulatory effects for IFNs have been 
described. Interferons can be categorized into three classes. Type I IFNs include 
IFN-β and 13 extremely homologous IFN-α subtypes. Type I IFNs are produced by 
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nearly all cells but APCs, especially pDCs, produce the highest levels of these 
cytokines (93, 171). Type I IFNs regulate the expression of several genes involved in 
the innate immune response. The expression of many PRRs, transcription factors, 
cytokines, chemokines and cytokine receptors is enhanced by IFNs (83, 171). 
Moreover, type I IFNs induce the production of important antiviral proteins including 
MxA, (2´-5´)oligo(A) synthetase (OAS) and protein kinase R (PKR) (83, 171). Type I 
IFNs also regulate the development of adaptive immunity. They enhance antigen 
processing, DC maturation and promote Th1 polarization (10, 83). Type I IFNs 
modulate gene expression by activating the Janus kinase-signal transducer and 
activator of transcription (Jak-STAT) transcription factor pathway (90). 
IFN-γ is the only type II IFN. This cytokine is primarily produced by T and NK cells 
although there is evidence that APCs can also produce IFN-γ in response to an 
appropriate stimulus. IFN-γ has an important role in dictating T cell polarization as it 
promotes Th1 and inhibits Th2 polarization of naïve T cells (177). IFN-γ also 
enhances macrophage activation and cytokine production and several chemokines, 
including CCL2, CCL3, CCL5, CXCL9 and CXCL10 are IFN-γ regulated. IFN-γ
also enhances NK cell activation (43, 160).  
The most recently discovered IFN class is type III IFNs, also known as IFN-λs, 
which consist of three homologous genes IFN-λ1-3 (also designated IL-28A, IL-28B 
and IL-29) (82, 162). Type I and III IFNs have similar antiviral functions but the 
genes are located in different chromosomes and they use different cell surface 
receptors to mediate their functions (82, 106, 137, 162).  
IL-12 cytokine family 
 The members of the IL-12 cytokine family, namely IL-12, IL-23 and IL-27, 
regulate T cell activation and polarization. These cytokines are produced primarily 
by macrophages and dendritic cells. IL-12 family cytokines are heterodimers. IL-12 
is composed of p35 and p40 subunits, IL-23 is made of p19 and p40 subunits, and 
IL-27 is composed of p28 and EBI3 (65). APC-derived IL-12 has long been known 
to be crucial for the development of Th1 cells and to induce T cell IFN-γ production 
(65, 177). IL-23 and IL-27 were also initially described as Th1 cytokines but 
recently their role in the regulation of T cell response has been clarified. IL-23 has 
been shown to promote the expansion of the newly discovered Th17 T cells, which 
contribute to several autoimmune inflammatory conditions (54, 79). IL-27 promotes 
Th1 polarization and suppresses the development of Th17 cells (23, 65). IL-12 
family of cytokines mediate their actions through the Jak-STAT signal transduction 
pathway (90).  
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2.3.2 Chemokines 
One key element of a properly functioning immune system is the coordinated 
movement of immune cells. Depending on the type of microbe or site of 
inflammation right kinds of immune cells have to be recruited. Chemokines or 
chemotactic cytokines are responsible for controlling the leukocyte movement. 
Nearly all cell types are able to produce these proteins in response to microbes or 
cytokine stimulus. In recent years several functions, in addition to chemotaxis, have 
been described for chemokines. Chemokines and chemokine receptors have been 
shown to be involved in embryogenesis, organ development, angiogenesis/ 
angiostasis, tumor metastasis, and binding of HI-virus to its target cells. Currently 
over 50 human chemokines have been described. Reviewed in (85, 135, 150, 205)  
Chemokines are small 8- to 15-kD proteins and they can be classified into four 
families on the basis of conserved N-terminal cysteine residues. In the CC family 
chemokines the two cysteines are adjacent, while in the CXC family chemokines 
there is one intervening amino acid between the cysteine residues. Most known 
chemokines belong to these CC or CXC families. The two minor chemokine groups 
are CX3C and C families which have only one and two members, respectively. The 
CXC chemokines can be further divided into ELR (Glu-Leu-Arg)-motif positive and 
–negative chemokines. This has also a functional relevance, since ELR+CXC
chemokines act as angiogenic factors, while most ELR-CXC chemokines are 
angiostatic (119, 174). Although different chemokines have overlapping functions in 
leukocyte chemotaxis some generalizations on their target cells can be made. The 
CC family chemokines are chemoattractants to one or several types of mononuclear 
leukocytes, eosinophils or basophils (85, 94). In contrast, ELR+CXC chemokines 
attract neutrophils and ELR-CXC chemokines recruit T lymphocytes (85, 94). 
Chemokines can also be classified on the basis of their functionality into 
homeostatic and inflammatory chemokines. Members of the former subset regulate 
leukocyte haematopoiesis in the bone marrow and thymus, and guide the leukocyte 
migration to spleen and lymph nodes. Inflammatory chemokines primarily control 
leukocyte traffic during an acute infection, inflammation or tissue injury. 
Inflammatory chemokines include several members of the CC and CXC chemokines 
and they mainly attract monocytes, neutrophils, NK cells, immature DCs and T 
cells. These cells have a key role in innate and adaptive anti-microbial defence. 
Some inflammatory chemokines, including CCL2 and CCL5, have also been shown 
to take part in T cell polarization (135, 199). In this thesis work the focus has been 
in analysing the production and gene regulation of inflammatory chemokines during 
microbial attack. The properties of inflammatory chemokines analyzed in this study 
are summarized in Table 3.  
33
Inflammatory chemokines are produced locally in infected tissues where they form a 
chemokine gradient by binding to extracellular matrix (150, 154). The gradient is 
recognized by leukocytes via their cell surface chemokine receptors. Binding of a 
chemokine to its receptor results in the expression of adhesion molecules, tissue 
modifying enzymes and leads to rearrangement of the cytoskeleton. These 
functional changes enable rolling leukocytes to bind endothelium and to 
transmigrate through cell junctions to the site of inflammation to perform their 
effector functions. 
Chemokines transduce signals via G-protein coupled, seven-transmembrane domain 
receptors, also known as serpentine receptors. The receptors are also categorized 
into CCR, CXCR, CX3CR and CR families. Currently 19 human chemokine 
receptors are known (150, 205). The key element of chemokine system is that the 
expression of chemokine receptor determines cell type specificity of a given 
chemokine. There is, however, significant redundancy in the chemokine system, 
since some chemokine receptors can bind multiple ligands with different affinity. 
Therefore, several chemokines have overlapping functions and can compensate each 
other. Ligand binding to chemokine receptor results in receptor dimerization and 
uptake of receptor to intracellular compartments. Receptor uptake desensitizes cells 
for further chemokine stimulus. Activated receptor is bound to G proteins and 
initiates multiple downstream signalling cascades including phospholipase C (PLC), 
phosphoinositode-3 kinase-gamma (PI3Kγ), and MAP kinases (109). Some 
chemokines, including CCL5 and CXCL12, also activate the Jak-STAT pathway 
(144, 147).  
Chemokine production and the expression of chemokine receptors is not static but 
may change during the course of inflammation. One example of this is seen during 
microbe-induced DC maturation. Immature DCs are recruited to infected tissues via 
CCR1, 2, 3, 4, and especially CCR6 binding chemokines (51). Maturation leads to a 
change in chemokine receptor pattern as CCR6 is down-regulated and the lymph 
node-homing receptor CCR7 is up-regulated (156). Mature DCs thus respond to 
CCR7 ligands CCL19 and CCL21, which are produced in lymphatic vessels, and are 
directed to local lymph nodes, where antigen presentation to T cells may take place 
(51, 169).  
34
Table 3. Inflammatory chemokines analysed in the present study  
Chemokine Additional name(s) Receptor(s) Target cell(s) 
CCL2 MCP-1, MCAF CCR2,10 Monocytes, basophils, 
T and NK cells 
CCL3 MIP-1α  CCR1,5 Monocytes, 
granulocytes, T and NK 
cells, DCs 
CCL5 RANTES CCR1,3,5 Monocytes, 
granulocytes,  T and 
NK cells, DCs 
CCL7 MCP-3 CCR1,2,3,10 Monocytes, 
granulocytes, T and NK 
cells, DCs 
CCL19 MIP-3β, ELC, Exodus-3 CCR7 Mature DCs, T cells, B 
cells, activated NK cells 
CCL20 MIP-3α, LARC, 
Exodus-1 
CCR6 Immature DCs, T cells 
    
CXCL8 IL-8  CXCR1,2 Neutrophils, T cells 
CXCL9 MIG CXCR3 NK and Th1 cells 
CXCL10 IP-10 CXCR3 NK and Th1 cells 
Adapted from (22, 85, 150) 
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2.3.3 Regulation of cytokine and chemokine gene expression 
Inflammatory cytokines and chemokines are produced rapidly following microbial 
attack. The expression of these genes is controlled primarily at a transcriptional level 
by binding of transcription factors to their target elements on gene promoters. Most 
cytokine and chemokine genes are regulated by NF-κB, IRF, STAT and MAPK-
activated transcription factors. These are also the transcription factor pathways most 
prominently activated via pattern recognition receptors. However, cytokines 
themselves also activate these transcription factors, thereby creating positive (and 
negative) feedback mechanisms. Thus, both direct (PRR-mediated) and indirect 
(cytokine-mediated) mechanisms are involved in the regulation of cytokine and 
chemokine production during microbial infections.  
Nuclear factor kappa-B pathway 
The NF-κB pathway is essential in controlling innate and adaptive immune 
responses. During the activation of innate immunity NF-κB regulates the expression 
of several cytokines, chemokines, antimicrobial peptides and stress response 
proteins (91, 180). NF-κB is a dimeric transcription factor which consists of five 
members, namely p65 (RelA), p50, p52, c-Rel and RelB. Under steady-state 
conditions NF-κB proteins are retained in the cytoplasm in association with 
inhibitory-κB (IκB) proteins. Upon activation, the inhibitory proteins are 
phosphorylated by IκB kinases (IKKα/β/γ) and subsequently targeted for 
degradation, which enables the translocation of NF-κB dimers into nucleus (91). In 
the nucleus NK-κB dimers bind to their target DNA sequences and associate with 
co-activation proteins such as cAMP responsive element binding (CREB) protein to 
enhance transcription. NF-κB pathway is induced by a variety of signals including 
cytokines, PRR-mediated microbe detection or DNA damage (91, 180).  
NF-κB target gene specificity is obtained by several mechanisms. Different NF-κB
proteins may form heterodimers with distinct DNA sequence preference. Also the 
expression of NF-κB components varies in different cell types. Recent evidence 
suggests that the efficiency of NF-κB dimer formation, DNA binding and 
association with co-activator proteins can be controlled by phosphorylation, 
acetylation or ubiquitination of NF-κB components. Reviewed in (19, 201).  
Interferon regulatory factors (IRFs) 
The IRF family of transcription factors consists of nine members. In recent years it 
has become evident that IRF activation via TLRs and other PRRs has a critical role 
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in modulating the activation of innate immune response. IRF proteins contain a 
conserved DNA binding motif which binds to interferon stimulation responsive 
element (ISRE) sequences on target gene promoters. The ISREs were initially 
described in the promoters of IFN genes but they are also found in several other 
genes controlling immune defence and cellular differentiation (61, 184). Although a 
consensus ISRE sequence has been established it is likely that different IRF homo- 
or heterodimers have unique sequence preference, which creates specificity on their 
target genes. IRFs can also interact with other transcription factors and 
transcriptional regulators thereby generating further selectivity on target sequences. 
In the context of cytokine and chemokine expression IRF1, IRF3, IRF4, IRF5 IRF7, 
IRF8 and IRF9 have been most extensively studied. IRF1 controls the expression of 
several innate immune genes including NOS2, gp91PHOX, IL-12, IL-15 and caspase-
1 (61, 184). The expression of type I IFNs and some chemokines is controlled by 
IRF3 and IRF7, which are retained in the cytoplasm under steady-state conditions. 
Upon TLR triggering IRF3 and IRF7 are serine phoshorylated by TANK-binding 
kinase (TBK)-1 and IKKε kinases, which enables nuclear translocation and DNA 
binding of IRF3/7 (35, 161). The induction of IFNs and involvement of IRF3/7 in 
this process is, however, also cell type and TLR-specific since in pDCs IRF7 
interacts directly with TLR7/9-MyD88-TRAF6 complex and induces rapid and 
efficient IFN production (60). TLR-induced expression of pro-inflammatory 
cytokines TNF-α, IL-6 and IL-12 was recently shown to be mediated by IRF5 (181). 
Upon TLR-activation IRF5 interacts directly with TLR-MyD88-TRAF6 complex 
which leads to IRF5 nuclear localization and gene expression. It was also 
demonstrated that IRF5-mediated cytokine response is negatively regulated by IRF4 
(62, 127). IRF8 regulates microbe-induced IL-12 production and the development of 
certain (mouse) DC types (39, 158, 159). IRF9 is constantly localized in the nucleus 
and it associates with STAT1 and STAT2 upon IFN-α/β stimulation. This complex 
is termed interferon stimulated gene factor (ISGF)3 and it regulates the expression 
of IFN-inducible genes (53, 80). 
Signal transducers and activators of transcription (STATs) 
STAT transcription factor family has seven members; STAT1, STAT2, STAT3, 
STAT4, STAT5a, STAT5b and STAT6. STATs mediate intracellular signalling of 
several cytokines, growth factors, hormones and chemokines. STAT activation is 
initiated by binding of ligand to its cell surface receptor. Ligand binding results in 
receptor multimerization and phosphorylation of receptor-associated Jaks. This leads 
to recruitment and subsequent phosphorylation of STATs, which form dimers or 
multimers and localize into nucleus. STATs bind to gamma-activated site (GAS) or 
ISRE elements on target gene promoters and gene specificity is achieved by distinct 
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sequence preference of different STAT dimers. Four Jaks have been described and 
they associate with different cytokine receptors, which creates specificity to 
cytokine-induced STAT-mediated gene expression. Reviewed in (89, 90).  
STATs regulate the expression of several important immune response genes. These 
include many chemokines, co-stimulatory molecules, MHC class I and II molecules, 
and complement proteins (89, 90, 171). These genes are often activated by IFN-
induced STAT1 and/or STAT2 activation.  Type I IFNs induce the formation of 
STAT1/2 heterodimers, which can associate with IRF9. This ISGF3 complex binds 
to ISRE/GAS sites on several cytokine and chemokine genes. IFN-γ, in contrast, 
induces STAT1 homodimerization which in part explains the differences in target 
genes of type I and type II IFNs (160). STATs also regulate cellular differentiation 
and the development of adaptive immunity. T cell polarization is critically regulated 
by STAT4 and STAT6. Type I IFNs and IL-12 activate STAT4 which results in Th1 
polarization, while IL-4 and IL-13 induce STAT6 activation and drive Th2 
polarization (200).  
2.4 Gram-positive bacteria 
Eubacteria can be classified into Gram-negative and Gram-positive bacteria on the 
basis of bacterial cell wall structure. The cell wall of Gram-negative bacteria is 
multilayered and consists of LPS on the outer cell membrane and smaller amounts 
of PGN. In contrast, the cell wall of Gram-positive bacteria is composed of a single 
layer of PGN together with teichoic and lipoteichoic acids. In this thesis work the 
activation of macrophage and dendritic cell inflammatory cytokine and chemokine 
response to Gram-positive bacteria was analyzed. Pathogenic Streptococcus 
pyogenes and non-pathogenic Lactobacillus rhamnosus were used as model bacteria. 
2.4.1 Streptococcus pyogenes 
S. pyogenes (Group A streptococcus) is an important pathogen, which exclusively 
infects humans. The infections caused by S. pyogenes vary from relatively mild and 
self-limiting skin and throat infections to severe tissue damage (115). However, 
humans are also often non-symptomatic carriers of this bacterium. S. pyogenes has 
several virulence factors. The invasion and spreading of S. pyogenes is promoted by 
the production of extracellular proteins including steptolysin S and O, several 
proteases and streptococcal DNAse (26). The M protein and hyaluronic acid capsule 
inhibit opsonin-mediated phagocytosis of S. pyogenes (26, 31). Moreover, S.
pyogenes produces at least seven exotoxins which act as superantigens and induce 
non-specific activation and cytokine production of T cells (26, 105, 170). The innate 
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immune defence against S. pyogenes relies on neutrophils and macrophages, which 
phagocytose and kill S. pyogenes. A critical role of macrophages in controlling the 
spread of S. pyogenes and systemic bacterial load was recently demonstrated in mice 
depleted of macrophages. Macrophage-depleted mice showed high mortality in 
response to the infection, while control mice survived the bacterial challenge (42). 
The ability of S. pyogenes or its LTA and exotoxins to induce inflammatory 
cytokine production in whole blood, PBMCs, and monocytes has been well 
documented (56, 122, 123, 129, 190). However, S. pyogenes–induced macrophage 
and dendritic cell activation is relatively poorly characterized. The PRRs mediating 
S. pyogenes-induced gene expression have not been analyzed in detail. Data from 
our laboratory indicate that TLR2, the stereotypical receptor for Gram-positive 
bacteria, at least partially mediates S. pyogenes-induced NF-κB activation in 
macrophages (Miettinen et al unpublished data). Data from other streptococci 
indicate that both TLR-dependent and TLR-independent mechanisms may be 
involved in streptococci-induced intracellular signalling. For example, the 
expression of several inflammatory cytokine and chemokine genes was delayed but 
not absent in Group B streptococci-stimulated TLR2 knockout macrophages (29, 57, 
58). The contribution of intracellular NOD2 receptor has been demonstrated in 
pneumococci-induced NF-κB activation (136). Gram-positive bacteria-induced 
signal transduction can also be induced via scavenger receptors. For example CD36 
mediates the uptake and intracellular signalling of S. aureus (175). Data from 
experiments performed with other bacteria should, however, be generalized with 
care since even subtle differences in cell wall protein composition and structure, or 
the expression of protective capsule can significantly alter the uptake, detection and 
intracellular signalling induced by different bacterial species. Moreover, the receptor 
usage is likely to vary between different cell types.  
2.4.2 Lactobacillus rhamnosus 
L. rhamnosus is a non-pathogenic lactic acid bacterium originally isolated from the 
human intestine. L. rhamnosus is widely used in dairy industry as a probiotic 
supplement. In recent years increasing interest has focused on probiotic bacteria. 
Most probiotic bacteria used and studied belong to Lactobacillus or Bifidobacterium
genera. The best documented beneficial effects of probiotic bacteria include reduced 
susceptibility to diarrhea caused by rotavirus infection or antibiotic treatment (25, 
178, 191). In addition, probiotic bacteria have been shown to have 
immunomodulatory effects including decreased incidence of atopy or allergy and 
reduction of the symptoms of chronic intestinal inflammation (reviewed in 157). The 
clinical data is still preliminary and partially contradictory and additional well 
controlled studies are required to elucidate the potential of probiotics in treating 
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these diseases. Moreover, the mechanisms are ill defined and rather speculative. It 
has been suggested that probiotic bacteria-induced cytokine production or 
modulation of intestinal APC functions by these bacteria could balance and/or 
enhance the functionality of intestinal immune system.   
Probiotic bacteria-induced cytokine production has been studied in several models. 
Human PBMCs produce both pro-inflammatory and immunosuppressive cytokines, 
including IL-10 and TGF-β in response to Lactobacillus species (18, 112, 114, 133). 
In these studies the differences between different bacterial species have been mostly 
quantitative. Dendritic cells are an important link between innate and adaptive 
immune responses and, depending on the stimulus, DCs can induce Th1, Th2 or 
tolerogenic T cell response. Thus, the modulation of DC functions could provide one 
mechanism for the proposed immunological effects of probiotic bacteria. Several 
recent reports have addressed the ability of different Lactobacilli to induce cytokine 
production in DCs. In contrast to PBMCs, DCs show dramatic bacterial species-
specific variability in their cytokine response to different Lactobacilli. For example, 
L. rhamnosus, Lactobacillus plantarum and Lactobacillus casei induce only weak 
cytokine production in DCs (11, 12, 28, 77, 203), while Lactobacillus acidophilus, 
Lactobacillus johnsonii, Lactobacillus reuteri and Lactobacillus gasseri efficiently 
induce the production of pro-inflammatory cytokines and IL-12 in DCs (20, 117, 
203). Importantly, T cell polarization induced by Lactobacilli-stimulated DCs has 
been shown to correlate with the ability of different species to induce DC activation 
and cytokine production. Lactobacillus species that do not induce DC cytokine 
production result in non-Th1/Th2 or tolerogenic T cell response while IL-12 
inducing species enhance Th1 polarization (11, 12, 117, 168). Although these in 
vitro studies do not directly give mechanistic explanation to the possible systemic 
immunomodulation by probiotic bacteria they clearly demonstrate that probiotic 
bacteria modulate APC functions and the development of adaptive immune 
responses. Moreover, the requirement of intestinal microbiota for the development 
and maintenance of properly functioning intestinal immune system is well 
recognized (97, 130). 
Only few studies have addressed the recognition and signal transduction induced by 
lactobacilli. Purified LTAs from several Lactobacillus species induce macrophage 
activation via TLR2 (104). However, in a transfection model L. reuteri, L. casei or L.
plantarum did not induce TLR-mediated NF-κB activation (168). Binding of L. casei
and L. plantarum on mo-DCs has been shown to be mediated by DC-SIGN (168). 
Moreover, the DC-SIGN-mediated signals were required for the proliferation of 
regulatory T cells induced by L. casei and L. plantarum-stimulated mo-DCs (168). 
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3 AIMS OF THE STUDY 
Macrophages and dendritic cells control innate antimicrobial responses and the 
subsequent development of adaptive immunity. Activated macrophages and 
dendritic cells produce cytokines and chemokines, which have an essential role in 
regulating both innate and adaptive immune responses. In this thesis work the 
activation and cytokine/chemokine response of different antigen presenting cell 
types in response to pathogenic and non-pathogenic Gram-positive bacteria was 
analyzed. Another key question of this study was the role of pro-inflammatory 
cytokines in the regulation of bacteria and influenza A virus-induced inflammatory 
chemokine gene expression.  
The specific aims of this study were: 
• To characterize the chemokine gene expression profile of human monocyte-
derived macrophages stimulated with pathogenic S. pyogenes and non-pathogenic L.
rhamnosus.
• To analyze the activation of monocyte-derived DCs and blood primary DCs in 
response to Gram-positive pathogenic and non-pathogenic bacteria 
• To characterize the role of pro-inflammatory cytokines in the regulation of 
inflammatory chemokine gene expression in macrophages and epithelial cells 
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4 MATERIALS AND METHODS 
4.1 Cell culture 
Most of the experiments in this thesis were performed with primary human 
leukocytes. These cells were isolated form leukocyte-rich buffy coats obtained from 
Finnish Red Cross Blood Transfusion Service. In each experiment cells from two to 
four donors were used. Macrophages and mo-DCs were differentiated in vitro from 
monocytes, while blood primary mDCs and pDCs were isolated from PBMCs by 
using magnetic separation and stimulated subsequently in vitro with different 
microbes. The methods are described below in brief, detailed descriptions can be 
found in the original publications. 
4.1.1 Isolation of PBMCs (I, II, III) 
PBMCs were isolated by Ficoll density gradient centrifugation after which the 
mononuclear cell layer was collected and washed. Monocytes were separated by 
allowing them to adhere to plastic cell culture plates and the non-adherent cells were 
removed by washing with phosphate-buffered saline (PBS) solution. When mo-DCs 
were generated, monocytes were further purified by an additional Percoll gradient 
centrifugation step followed by magnetic depletion of T cells and B cells prior to 
cell adherence. 
4.1.2 Differentiation of macrophages and DCs 
Macrophages were cultured in serum-free macrophage medium (Gibco) 
supplemented with antibiotics, glutamine and 10 ng/ml of GM-CSF for 7d. Fresh 
medium was changed every two days. Mo-DCs were cultured in RPMI1640 medium 
(Sigma) supplemented with antibiotics, glutamine, 10 % fetal calf serum (FCS), 10 
ng/ml of GM-CSF and 20 ng/ml of IL-4. Fresh medium was added every two days. 
After 6-7 d culture mo-DCs were mostly non-adherent and expressed DC-specific 
cell surface proteins.  
4.1.3 Isolation of blood primary DCs and CD4+ T lymphocytes 
Blood primary DCs were isolated from PBMCs by using magnetic separation 
methods. pDCs were isolated by positive selection using BDCA4 dendritic cell 
isolation kit  (Miltenyi Biotec). mDCs were isolated with BDCA1 DC isolation kit 
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(Miltenyi Biotec). Isolated pDC were CD123+ BDCA2+ double-positive and no 
CD11c expression was detected. mDCs were over 95% CD11c positive and showed 
no expression of pDC markers. pDCs were cultured in RPMI1640 medium 
supplemented with antibiotics, glutamine, 10 % FCS and 10 ng/ml of IL-3. mDCs 
were cultured in the same medium as mo-DCs. Naïve CD4+ T cells were isolated 
from cord blood by negative selection using CD4+ T cell isolation kit II (Miltenyi 
Biotec). The purity of CD4+ cells was over 95 %.  
4.1.4 Cell lines 
The A549 lung adenocarcinoma cell line (ATCC CCL-185) was obtained from 
American Type Culture Collection. Cells were grown in plastic cell culture flasks in 
Eagle-MEM (Sigma) supplemented with antibiotics, glutamine and 10 % FCS.  
4.2 Bacteria and viruses used (I, II, III, IV) 
S. pyogenes serotype T1M1 (IH32030), isolated from a child with bacteremia was 
obtained from the collection of National Public Health Institute (Helsinki, Finland) 
and L. rhamnosus GG (ATCC 53103) was from Valio R&D (Helsinki, Finland). S.
enterica serovar typhimurium (S. typhimurium) was obtained from Prof. Timo 
Korhonen. Bacteria were stored at -70°C and grown to logarithmic growth phase for 
stimulation experiments. Cells were stimulated with live bacteria unless otherwise 
indicated. Prior to stimulation, the bacteria were centrifuged and suspended to 
RPMI1640 medium and added to cells. Macrophages were stimulated at 1:1 
bacteria:macrophage ratio, while 5:1 ratio was determined to be optimal for DCs.  
Influenza A H1N1 (A/New Caledonia/20/99), influenza A H3N2 
(A/Beijing/353/89), influenza B (B/Victoria/2/87) and Sendai (strain Cantell) 
viruses were grown in 11 day-old embryonated eggs. Cells were infected with MOIs 
indicated in each experiment and egg allantois fluid was used in the mock/control 
infections.  
4.3 mRNA expression analyses (I, II, IV) 
Cells from four blood donors were pooled and total cellular RNA was isolated by 
guanidium isothiocyanate/CsCl method or by using RNeasy RNA isolation kit 
(Qiagen). RNA was quantified photometrically, and samples containing equal 
amounts (10 μg) of RNA were size-fractionated on 1 % formaldehyde-agarose gels, 
and transferred to nylon membranes. The probes for Northern blot analysis were 
labeled with [α-32P]dATP (3000 Ci/mmol) using random primed DNA labeling kit. 
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Hybridizations were performed in Ultrahyb buffer (Ambion). After hybridization the 
membranes were washed and exposed to Kodak X-Omat AR film at -70°C with 
intensifying screens. Details about the cDNA probes used can be found in the 
original publications. Equal sample loading was controlled by staining rRNAs with 
ethidium bromide.
4.4 Protein expression analyses 
4.4.1 Cytokine and chemokine measurements (I, II, III, IV) 
For the analysis of cytokine and chemokine production cell culture supernatants 
from different donors were pooled or analyzed separately (indicated in each original 
publication). Cytokine and chemokine levels were analyzed from cell culture 
supernatants by a sandwich-ELISA method. The antibody pairs and standards were 
obtained from BD Pharmingen, R&D Biosystems and Biosite (Details in the original 
publications). In publication III, the expression of pro-inflammatory and Th1/Th2 
cytokines was measured by using FlowCytomix bead assay (Bender Medsystems) 
and flow cytometry. 
4.4.2 Flow cytometry (II, III) 
For flow cytometric analysis, the cells from three to four blood donors were pooled 
after stimulation experiments. Cells were washed with PBS and fixed with 3 % 
paraformaldehyde. The expression of co-stimulatory molecules and pDC/mDC 
specific cell surface markers was analyzed by using FITC- or PE-conjugated 
antibodies and respective isotype controls. Cells were analyzed with FACScan flow 
cytometer and Cellquest software (BD Biosciences). 
4.4.3 Western blotting (IV) 
Cells from different donors were pooled and were lysed into TN-buffer containing 
protease inhibitors. Equal amounts of protein were separated on SDS-PAGE and 
transferred onto membranes. Membranes were stained in 5 % nonfat milk. Details 
about the antibodies used can be found in the original publications. Proteins were 
visualized by using the enhanced chemiluminescence system (Amersham). 
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4.5 Transcription factor activation analysis (IV) 
Transcription factor activation was studied by DNA affinity binding assay. Cells 
were lysed and samples were treated as described by Rosen et al (149). The 
oligonucleotides used were ISRE and NF-κB elements from CXCL10 promoter. The 
forward oligonucleotide was 5´-biotinylated and a BamHI site was added as a spacer 
between the biotin and transcription factor binding sequence. Detailed sequences are 
described in IV. Oligonucleotides were annealed in 0.5 M NaCl and incubated with 
streptavidin-agarose beads (Pierce) at +4°C for 2 h. The unbound oligonucleotide 
was washed, after which equal amounts of protein samples were incubated with the 
oligonucleotide bound agarose beads for 2 h at +4°C. After washings, the bound 
proteins were boiled in SDS sample buffer and separated on SDS-PAGE followed 
by Western blotting.  
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5 RESULTS AND DISCUSSION 
The aim of this thesis work was to analyze the activation and regulation of 
inflammatory cytokine and chemokine production in different cell types. More 
specifically, the ability of pathogenic S. pyogenes and non-pathogenic L. rhamnosus
to activate human monocyte-derived macrophages and mo-DCs was first evaluated 
(I, II). S. pyogenes was found to be an extremely potent activator of cytokine and 
chemokine production, while L. rhamnosus induced a more limited response 
especially in mo-DCs. In subsequent experiments the ability of S. pyogenes to 
activate blood primary DC subtypes was analyzed (III). S. pyogenes stimulation 
induced effective maturation and cytokine production of primary DCs. Interestingly, 
also pDCs that have been previously thought as “virus-restricted” DCs, were 
activated by S. pyogenes. Another key question of the present work was the role of 
pro-inflammatory cytokines in microbe-induced chemokine production. The results 
demonstrate that pro-inflammatory cytokines enhance microbe-induced production 
of certain inflammatory chemokines during infection and that pro-inflammatory 
cytokines can prime normally unresponsive cells for efficient microbe-induced 
chemokine production (I, IV).  
5.1 Macrophage chemokine response to Gram-positive bacteria (I) 
5.1.1 S. pyogenes and L. rhamnosus-induced chemokine production in 
macrophages 
Tissue resident macrophages have an important role in innate immune response 
against microbial pathogens. Activated macrophages ingest and kill microbes by 
phagocytosis and produce a large variety of cytokines and chemokines. Tissue 
macrophages are in the first line of anti-microbial defence and thus macrophage-
derived chemokines have a crucial role in recruiting other effector cells to the site of 
inflammation. Previous observations in our laboratory have shown that S. pyogenes
and L. rhamnosus induce the production of pro-inflammatory cytokines in 
macrophages and PBMCs (111, 112, 114). However, when this thesis work was 
initiated the ability of Gram-positive bacteria to induce inflammatory chemokine 
production had not been systematically analyzed. 
In our experimental setting human monocyte-derived macrophages were stimulated 
with live bacteria and the chemokine production was measured at mRNA and 
protein level. S. pyogenes- and L. rhamnosus-stimulated macrophages produced 
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similar patterns of inflammatory chemokines. These included CCL2, CCL3, CCL5, 
CCL7, CCL20 and CXCL8 (Figs. 1 and 2 of I). Subtle differences in the induction 
kinetics of these chemokines were observed at the mRNA level between S. pyogenes
and L. rhamnosus. However, at 24 h the protein levels measured from cell culture 
supernatants were similar between the two bacteria. The inflammatory chemokines 
produced by S. pyogenes- and L. rhamnosus-stimulated macrophages attract several 
effector cell types. CCL2, CCL3, CCL5 and CCL7 recruit monocytes, granulocytes 
and T cells, while CXCL8 attracts neutrophils (98, 124, 135). The production of 
CCL20 by macrophages has not been previously reported but it may have a critical 
role in the activation of adaptive immune response since this chemokine attracts 
immature DCs (51, 169). Bacteria-induced inflammatory cytokine and chemokine 
response of monocyte/macrophages has recently been addressed in several global 
gene expression analyses. Macrophages and mononuclear cells stimulated with 
Gram-positive or Gram-negative bacteria were found to express several 
inflammatory chemokines including CCL2, CCL3, CCL4, CCL5, CXCL8 together 
with pro-inflammatory cytokines (34, 125). In another report purified TLR2 and 
TLR4 ligands were shown to induce the production of CC-chemokines in human 
monocytes and in a monocytic cell line (138). In conclusion, these results 
demonstrate that macrophages produce a large number of cytokines and chemokines 
in response to both pathogenic and non-pathogenic bacteria. Macrophage-derived 
cytokines and chemokines enhance local immune defence and efficiently recruit 
additional effector cells to the inflammation site. 
5.1.2 Direct and indirect mechanisms of chemokine gene activation in 
bacteria-stimulated macrophages 
Certain important differences in the macrophage chemokine response were, 
however, noted between L. rhamnosus and S. pyogenes. Only S. pyogenes induced 
efficient production of CXCL9 and CXCL10, which are chemoattractants for Th1 
and NK cells (66, 121). The difference in the production of CXCL9 and CXCL10 
had also a clear functional effect as the migration of Th1 cells was markedly higher 
in response to supernatants from S. pyogenes-stimulated macrophages compared to 
supernatants from L. rhamnosus-stimulated macrophages (Fig. 6 of I). Since S. 
pyogenes is able to invade and exist intracellularly in epithelial cells and neutrophils 
(118), the production of CXCL9 and CXCL10 and resulting NK cell recruitment 
could have a role in enhancing the recognition and destruction of intracellular S.
pyogenes.
In the next set of experiments the mechanisms involved in the different expression 
of CXCL9 and CXCL10 in S. pyogenes and L. rhamnosus-stimulated macrophages 
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were evaluated. The mRNA and protein expression data showed that these 
chemokines were induced with a slower kinetics compared to other inflammatory 
chemokines. This suggested that the expression of CXCL9 and CXCL10 could be 
induced indirectly i.e. via the production of pro-inflammatory cytokines. To test 
whether bacteria-induced chemokine production was direct or cytokine-mediated 
macrophages were stimulated with bacteria in the presence of protein synthesis 
inhibitor cycloheximide. These experiments revealed that the bacteria-induced 
expression of CCL2, CCL7, CXCL9 and CXCL10 mRNAs was at least partially 
dependent on ongoing protein synthesis (Fig. 3 of I). At the protein level the clearest 
difference between L. rhamnosus and S. pyogenes was observed in the production of 
CXCL9 and CXCL10 suggesting that only S. pyogenes induced the mediator(s) 
enhancing the production of these chemokines. Our previous studies have shown 
that S. pyogenes but not L. rhamnosus induces IFN-α/β production in macrophages 
(111). Moreover, the expression of CXCL9 and CXCL10 has been shown to be 
inducible by IFNs and TNF-α (131, 132). In light of this information macrophages 
were stimulated with L. rhamnosus and S. pyogenes in the presence of neutralizing 
antibodies against type I IFNs. Neutralization of IFN-α/β during bacterial 
stimulation decreased S. pyogenes-induced CXCL9 and CXCL10 mRNA expression 
demonstrating a role of type I IFNs in enhancing S. pyogenes-induced expression of 
these chemokines. IFN-α/β most likely acts by inducing the formation of ISGF3 
complex, which can bind to ISRE element on the CXCL10 promoter. The combined 
results from cycloheximide and IFN-neutralization experiments show that bacteria-
induced expression of CXCL9 and CXCL10 is mediated by both direct microbe-
induced transcription factor activation and via positive feedback loop provided by 
IFN-α/β and possibly by other pro-inflammatory cytokines. However, IFN-α and 
especially TNF-α alone induced only low CXCL9 and CXCL10 mRNA expression 
in macrophages (Fig. 5 of I). When these cytokines were combined a strong 
synergistic induction was detected. Since CXCL9 and CXCL10 proximal promoters 
contain ISRE and NF-κB binding sites (131, 132) these results suggest that the 
activation of both NF-κB and STAT transcription factors, provided by TNF-α and 
IFN-α/β  or microbial stimulation is required for efficient CXCL9 and CXCL10 
expression. IFN-α/β mediated feedback loop has been shown to operate in LPS-
stimulated murine macrophages by enhancing the expression of iNOS, MCP5 and 
CXCL10 (38, 187).  
The finding that S. pyogenes is able to induce type I IFNs and IFN-inducible 
chemokines in macrophages is also of interest. The classical receptor for Gram-
positive bacteria is TLR2, which does not activate TRIF-mediated signal 
transduction pathway leading to type I IFN production. Thus, purified TLR2 ligands 
do not induce IFN production in macrophages (187). Moreover, when Nau and 
coworkers compared the gene expression pattern of macrophages stimulated with 
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Gram-positive and Gram-negative bacteria, the most significant differences were 
observed in the expression of IFN-inducible genes, which were only induced by 
Gram-negative bacteria (126).  These results suggest that S. pyogenes can induce 
macrophage activation and expression of IFN-inducible genes in a TLR2-
independent fashion. In recent microarray analysis it was shown that the activation 
of cytokine and chemokine genes by Group B Streptococcus is largely TLR2-
independent in macrophages. Bacteria-induced expression of CC-chemokines, 
CXCL10 and TNF-α was somewhat slower in TLR2 knockout mice but at late time 
points the expression levels were nearly similar compared to wild type mice (29). It 
is, however, likely that TLR2 contributes to streptococci-induced macrophage 
activation since neutralizing anti-TLR2 antibodies reduce S. pyogenes-induced NF-
κB activation (Miettinen et al unpublished results). Also, LTA from Group B 
streptococci has been shown to induce NF-κB activation and TNF-α production via 
TLR2/6 heterodimer (57). The TLR2-independent macrophage activation of S.
pyogenes could be mediated i.e. via TLR9, which recognizes unmethylated CpG-
rich DNA found in bacterial and viral genomes. However, in our experimental 
setting macrophages do not express this receptor (113). Another possibility could be 
intracellular NOD2 receptor, which has been shown to mediate S. pneumoniae-
induced NF-κB activation (136). However, NOD2 has not been shown to induce 
IRF or STAT activation or to induce the production of type I IFNs.  
In conclusion, these results show that both pathogenic and non-pathogenic Gram-
positive bacteria induce the production of inflammatory cytokines and chemokines 
in macrophages. Although there seems to be a “general proinflammatory cytokine 
set” composed of TNF-α, IL-6 and CC-chemokines, and this gene pattern is induced 
by Gram-positive and Gram–negative bacteria as well as TLR2/4 ligands, there are 
still major qualitative differences between bacterial species and strains in the gene 
expression profile induced. The differences probably indicate that some bacteria are 
able to activate intracellular signal transduction via multiple PRRs, which results in 
a broad expression of inflammatory genes. The results obtained here also 
demonstrate an important role of secreted pro-inflammatory cytokines in enhancing 
bacteria-induced chemokine expression by providing a positive feedback loop.   
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5.2 Activation of monocyte-derived DCs by Gram-positive 
bacteria (II) 
5.2.1 S. pyogenes and L. rhamnosus-induced mo-DC maturation 
When the DC study was initiated large body of evidence on the ability of TLR 
ligands and pathogenic microbes to induce DC activation was already available. 
However, far less was known on the ability of non-pathogenic bacteria, especially 
Gram-positive bacteria, to modulate DC functions. Thus, the methodology for DC 
isolation and culturing was set up. Previous studies had shown that the maturation of 
immature DCs results in significant changes in DC transcriptome, which renders 
DCs to efficient T cell activators. Microbe-stimulated DCs produce cytokines, 
chemokines, tissue remodeling enzymes and show enhanced expression of T cell-
stimulating cell surface molecules (47, 64, 84). In this study the maturation of mo-
DCs was characterized by analyzing the expression of cell surface co-stimulatory 
molecules and the production of cytokines and chemokines. To address the 
functional maturation of DCs, the effect of bacterial stimulation on DC endocytosis, 
which is known to be reduced during maturation, was analyzed.  
Both L. rhamnosus and S. pyogenes enhanced the expression of CD80, CD83 and 
CD86 co-stimulatory molecules in a bacterial dose-dependent manner (Fig. 1 of II). 
S. pyogenes-stimulated DCs showed slightly higher expression of CD83 and CD86 
compared to L. rhamnosus-stimulated cells. Enhanced expression of co-stimulatory 
molecules was seen after 12 h stimulation and it reached maximum levels at 24 h 
(unpublished data). S. pyogenes-stimulation also efficiently reduced the endocytosis 
of FITC-dextran by DCs (Fig. 5 of II). The reduction of DC endocytosis was less 
evident in L. rhamnosus-stimulated DCs suggesting that L. rhamnosus-stimulated 
DCs matured less well than S. pyogenes-stimulated DCs. In conclusion, S. pyogenes-
stimulated DCs showed a mature phenotype while L. rhamnosus-stimulated DCs 
had a more “semi-mature” DC phenotype. These DCs have been suggested to 
promote tolerance (152, 172). 
5.2.2 Distinct cytokine responses in S. pyogenes and L. rhamnosus-
stimulated mo-DCs 
When bacteria-induced cytokine and chemokine production was analyzed, a striking 
difference between S. pyogenes and L. rhamnosus was observed. Only S. pyogenes-
stimulation resulted in the production of pro-inflammatory cytokines and 
chemokines from mo-DCs (Fig. 2 of II). This was in stark contrast with our previous 
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findings on PBMCs or macrophages where the production of most pro-inflammatory 
cytokines and chemokines was induced in a nearly similar fashion by both S. 
pyogenes and L. rhamnosus (111, 112, 114, and I).  
S. pyogenes induced the production of Th1 recruiting CXCL9 and CXCL10 
chemokines and the production of IL-12. Moreover, the expression of IL-23 and IL-
27 subunits p19/p40 and p28/EBI3, respectively, was induced at mRNA level (Fig. 4 
of II). These results suggested that S. pyogenes-stimulated DCs could initiate 
efficient Th1 polarization. This was later demonstrated to be the case in S. pyogenes-
stimulated blood primary myeloid DCs which enhanced IFN-γ production from 
naïve CD4+ T cells (Fig. 6 of III). Interestingly, we observed that mo-DCs 
stimulated with S. pyogenes produced IL-2. The ability of DCs to produce IL-2 has 
previously been shown only in murine DCs (45, 46). In our experimental setting the 
inducible IL-2 production was restricted to S. pyogenes and not detected in mo-DCs 
stimulated with L. rhamnosus, S. typhimurium or LPS (Figs. 2 and 4 of II and 
unpublished observations). DC-derived IL-2 has been shown to play a role in 
enhancing T cell proliferation and NK cell activation in murine models (46, 48). The 
ability of S. pyogenes to induce the production of IL-2 in addition to IL-12 is likely 
to play a role in the efficient Th1 polarization induced by S. pyogenes.   
The finding that L. rhamnosus was unable to induce cytokine production in DCs was 
somewhat surprising as this bacterium was one of the best cytokine inducers in 
PBMCs (112, 114). Our results on the lack of cytokine response in L. rhamnosus-
stimulated mo-DCs have been confirmed in recent reports (11, 12, 203). The 
inability of L. rhamnosus to induce cytokine production can not, however, be 
generalized to whole lactobacillus genus. For example L. casei, L. reuteri and L.
johnsonii have been shown to efficiently induce TNF-α, IL-10, IL-12 and IL-18 in 
human mo-DCs (117, 203). In our ongoing experiments performed with more than 
ten different Lactobacillus and Bifidobacteria species we have observed that several 
Gram-positive bacteria from these genera are in fact efficient cytokine inducers in 
mo-DCs. L. rhamnosus-stimulated mo-DC showed a “semi-mature” phenotype. 
These DCs are partially matured but do not produce pro-inflammatory cytokines or 
IL-12. Moreover, these DCs have been suggested to be tolerogenic and promote the 
proliferation of regulatory T cells (152, 172). Thus, it could be speculated that L.
rhamnosus-stimulated DCs may enhance tolerance instead of inflammatory Th1 
response. Previous reports have shown that, depending on the Lactobacillus strain 
and experimental setting used, probiotic bacteria-stimulated DCs can induce the 
proliferation of regulatory T cells (55, 198) or promote Th1 polarization (117, 141). 
Most importantly, the polarization of T cell response correlates with the ability of 
bacteria to activate DCs. Since DCs are powerful modulators of the adaptive 
immunity and DCs are present in the gastrointestinal mucosal tissue, modulation of 
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DC functions could be one mechanism of the immunomodulatory effects of 
probiotic bacteria. These effects could include probiotic-induced activation and Th1 
polarization of the immune system during early childhood or perhaps enhancement 
of intestinal tolerance. However, these intriguing mechanisms remain speculative as 
no direct experimental data is currently available.  
5.2.3 L. rhamnosus and S. pyogenes differentially activate mo-DC 
transcription factor networks (unpublished results) 
In order to elucidate the mechanisms behind the distinct ability of S. pyogenes and L.
rhamnosus to induce mo-DC cytokine production we analyzed the transcription 
factor pathways activated by these bacteria. In macrophages both L. rhamnosus and 
S. pyogenes activate the NF-κB pathway (111). However, S. pyogenes is a more 
potent activator of STATs, IRF1 and the ISGF3 complex (111).  
Similarly to macrophages, both L. rhamnosus and S. pyogenes activated the NF-κB
pathway in mo-DCs (Fig. 2). DNA binding of the components of classical (p50/p65) 
and alternative (p52/RelB) NF-κB pathways was detected on CXCL10 NF-κB
element (Fig. 2). These results also confirmed that the difference between bacteria in 
the ability to induce mo-DC activation is not due to the lack of interaction between
L. rhamnosus and mo-DCs. A hallmark difference between bacteria was seen in the 
activation of IRFs and STATs. S. pyogenes induced the DNA binding of IRF1, 
IRF4, IRF7, IRF8, IRF9, STAT1 and STAT2 on CXCL10 ISRE element. In 
contrast, L. rhamnosus stimulation most prominently enhanced DNA binding of 
IRF4 while the activation of other IRFs and STATs was weak and only detected 
after 24 h stimulation. This is of interest, since IRF4 has recently been suggested to 
act as a negative regulator of TLR-mediated cytokine expression (62, 127). Thus, it 
could be speculated that L. rhamnosus-induced activation of IRF4 may reduce DNA 
binding of activating IRFs or STATs, which could limit cytokine and chemokine 
gene expression. Further studies are on the way to elucidate the contribution of 
differential IRF activation on distinct cytokine and chemokine response observed in 
S. pyogenes and L. rhamnosus-stimulated mo-DCs. 
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Figure 2.  S. pyogenes and L. rhamnosus-induced NF-κB, IRF and STAT activation 
in mo-DCs. DCs were stimulated with bacteria for the times indicated and 
the DNA binding of transcription factors was analyzed by oligonucleotide 
affinity binding assay by using NF-κB and ISRE elements from CXCL10 
proximal promoter. The classical (p50/p65) and alternative (p52/RelB) NF-
κB pathway was similarly activated by both bacteria. In contrast, IRFs and 
STATs were activated efficiently only by S. pyogenes.  
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5.3 Activation of blood primary DCs by bacteria and influenza A 
virus (III) 
Recent advances in cell isolation techniques and the discovery of novel DC subtype-
specific molecules has enabled the isolation of primary human mDCs and pDCs 
from peripheral blood. Since our findings on macrophages and mo-DCs had shown 
that S. pyogenes is an extremely potent APC activator we broadened the analysis to 
primary mDCs and pDCs. Moreover, the possible involvement of pDCs in 
antibacterial defence has not been previously elucidated in detail. Early reports, 
however, suggested that Gram-positive S. aureus could activate pDCs (165).  
In the first set of experiments the ability of bacteria to induce pDC activation was 
analyzed. LPS was used as a negative control since pDCs do not express TLR4 and 
are therefore unresponsive to LPS (93). In these preliminary experiments, we 
observed that S. pyogenes induced significant TNF-α production in pDCs whereas 
L. rhamnosus, Gram-negative S. typhimurium or LPS failed to induce TNF-α (Fig. 1 
of III and data not shown). A well characterized pDC activator, influenza A virus, 
was a more potent TNF-α inducer than S. pyogenes. When DC maturation was 
analyzed, we observed that S. pyogenes and influenza A virus enhanced the 
expression of CD40, CD86 and MHCII in pDCs (Fig. 3 of III). At 24 h, influenza A 
virus induced the expression of co-stimulatory molecules better that S. pyogenes but 
at 48 h the expression levels were equal. Unstimulated mDCs already expressed 
high levels of co-stimulatory molecules and the expression of CD40, CD86 and 
HLAII was enhanced only marginally in response to S. pyogenes. mDCs were very 
sensitive to the cytopathic effects of influenza A virus, which was observed in the 
viability assay as well as in the inability of influenza A virus to enhance the 
expression of co-stimulatory molecules in mDCs (Figs. 2 and 3 of III).  
Both S. pyogenes-stimulated pDCs and mDCs produced pro-inflammatory cytokines 
TNF-α and IL-6 together with CCL3 and CXCL8 (Figs. 4 and 5 of III). However, 
certain differences in the cytokine profiles of mDCs and pDCs were also observed. 
Most importantly, only mDCs produced IL-10 and IL-12 in response to S. pyogenes.
Although early reports suggested that pDCs are able to produce IL-12, more recent 
studies have shown that human pDCs do not produce IL-12 (69, 70, 120). The 
absence of IL-12 in S. pyogenes-stimulated pDC supernatants also confirms that S.
pyogenes-induced production of other inflammatory cytokines and chemokines is 
not mediated by contamination with myeloid cells. Another difference was observed 
in the production of IFN-α, which was only detected in influenza A virus-stimulated 
pDCs and mDCs. However, influenza A virus-induced cytokine response was 
generally very low in mDCs, which is associated with the high susceptibility of 
these cells to influenza A virus infection.  
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Our observations in S. pyogenes-stimulated macrophages and mo-DCs demonstrated 
that this bacterium induces a strong Th1 type cytokine response including the 
production of IL-12 and IL-27 and Th1 recruiting chemokines CXCL9 and CXCL10 
(111, I and II). In line with this data we detected Th1 type IFN-γ production from 
naïve T cells co-cultured with S. pyogenes-stimulated mDCs and pDCs (Fig. 6 of 
III). S. pyogenes-stimulated pDCs also induced the production of IL-10 from T cells. 
It could be speculated that pDCs can polarize T cells towards mixed Th1 and 
regulatory T cell population. It is likely that other mediators apart from IL-12 and 
IFN-α regulate pDC-induced Th1 polarization, since these cytokines were not 
produced by S. pyogenes-stimulated pDCs. Virus- or CpG-DNA-stimulated pDCs 
have been previously shown to induce the proliferation of Th1 cells and regulatory T 
cells with CD4+CD25+ phenotype (16, 78, 120).  
The receptor mediating S. pyogenes–induced pDC responses remains to be further 
characterized. pDCs do not express TLR2, the prototype receptor for Gram-positive 
bacteria (72, 74). An obvious receptor candidate is TLR9 which recognizes CpG-
rich DNA found in bacteria and DNA viruses (7, 93). However, S. pyogenes-induced 
TNF-α production was unaffected when inhibitory CpG oligonucleotides or non-
specific TLR9 inhibitor chloroquine was used during stimulation (unpublished 
observations). Other alternatives for the S. pyogenes receptor include scavenger or 
lectin-type receptors, which are broadly expressed in pDCs (9, 93). Although the 
role of these receptors in regulating pDC maturation and cytokine production has so 
far remained uncharacterized, recent reports have show that these receptors, 
including Dectin-1 and DC-SIGN, activate intracellular signalling and cytokine 
production in other cell types (14, 148, 189). 
Certain differences in S. pyogenes-stimulated mDCs and mo-DCs were observed. In 
our experimental setting S. pyogenes-stimulated mDCs produced high levels of IL-
10 within 24-48 h, while the IL-10 production in mo-DCs was low and detectable 
only after 48 h S. pyogenes stimulation (unpublished observations). Unexpectedly, 
no IL-2 or CXCL10 was detectable in mDC supernatants although these mediators 
were produced by S. pyogenes-stimulated mo-DCs. Thus, although similar in many 
aspects, mDCs and mo-DCs have also differences in their microbial responses.  
In conclusion, these results show that human primary DCs are efficiently activated 
by S. pyogenes. Interestingly, also pDCs, which have previously been thought to be 
“virus-specific” DCs, matured and produced inflammatory cytokines and 
chemokines in response to S. pyogenes. Thus, the different human DC subtypes may 
have more functional flexibility in their bacterial responses than previously 
anticipated. These results also demonstrate that S. pyogenes efficiently activates 
several APC types, including macrophages, mo-DCs, mDCs and pDCs, and 
promotes the production of inflammatory cytokines and chemokines. The activation 
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several APCs may provide effective means for the host to control S. pyogenes
infections. However, the high potency of S. pyogenes to induce cytokine and 
chemokine production may also play a role in severe group A streptococcal 
infections, which are characterized by extensive inflammation and tissue damage. S.
pyogenes-induced excessive APC activation could also contribute to the 
development of post-streptococcal autoimmune diseases such as rheumatic heart 
disease and psoriasis (5, 8). 
5.4 Regulation of influenza A virus-induced chemokine gene 
expression by pro-inflammatory cytokines (IV) 
The results from publication I clearly demonstrated a role of pro-inflammatory 
cytokines, especially that of type I IFNs, in enhancing bacteria-induced chemokine 
production (I). In that setting type I IFNs and/or other pro-inflammatory cytokines 
were likely to directly activate transcription factors and enhance chemokine 
production during bacterial stimulation. Pro-inflammatory cytokines, however, also 
increase the expression of several transcription factors and PRRs, which could 
promote microbial recognition and signal transduction. To evaluate this aspect of 
pro-inflammatory cytokines in the regulation of chemokine production, we studied 
the effect of TNF-α and IFN-α priming on influenza A virus-induced chemokine 
production in human lung epithelial cells.  
5.4.1 Influenza A virus-induced chemokine production and transcription 
factor activation 
When A549 lung epithelial cells were infected with influenza A virus the expression 
of inflammatory chemokine genes was relatively weak and detected only when the 
highest viral doses were used (Figs. 1 and 2 of IV). To test the effect of cytokine 
priming, cells were treated with TNF-α or IFN-α prior to influenza A virus 
infection. After cytokine priming influenza A virus-induced expression of CCL2, 
CCL5, CXCL8 and CXCL10 was significantly enhanced (Fig. 3 of IV). Most 
importantly, cytokine priming enhanced the DNA binding of IRF1, IRF3 and IRF7 
on CXCL10 ISRE element and NF-κB binding on CXCL10 NF-κB element. 
Without cytokine pre-treatment influenza A virus induced DNA binding of IRFs 
was undetectable and NF-κB DNA binding was only seen at 24 h post infection 
(Fig. 5 of IV).
56
5.4.2 Mechanisms of the enhanced chemokine response by cytokine pre-
treatment 
The above results clearly showed that TNF-α and IFN-α pre-treatment enhances 
virus-induced chemokine production. We hypothesized that this could be mediated 
by enhanced expression of signal transduction components and/or PRRs. Previous 
studies have shown that the expression of IRF1, IRF7 and STATs is IFN-inducible 
(4, 87, 100). Moreover, the expression of many TLRs and the recently described 
intracellular dsRNA sensor RIG-I is regulated by IFNs (113, 202). Similarly to these 
results, TNF-α and/or IFN-α enhanced the expression of IRF1 and IRF7 and their 
upstream components IKKε and RIG-I in A549 cells (Fig. 4 of IV). Another 
mechanistic explanation in virus model could be that TNF-α or IFN-α reduce virus 
replication and limit the expression of viral proteins that may down-regulate 
cytokine and chemokine production. For example, influenza A virus encodes non-
structural (NS)1 protein which interferes with host cell mRNA processing and 
inhibits RIG-I-dependent activation of intracellular signalling (128, 140). However, 
no significant reduction in viral gene expression was observed at mRNA or at 
protein level in cytokine pre-treated cells compared to untreated cells (Figs. 3 and 5 
of III). The cytokine pre-treatment also enhances TLR ligand-induced IFN 
production (167), which further suggests that the mechanism of cytokine pre-
treatment relies on enhanced expression of PRRs and signal transduction 
components, not on mere inhibition of virus replication. 
In conclusion these results show that pro-inflammatory cytokines can render 
normally unresponsive cells to high chemokine producers upon viral infection. The 
cytokine priming and the resulting increased chemokine response most likely 
enhances the migration of effector leukocytes to the site of inflammation and 
promotes more efficient resolution of the inflammation. Although influenza A virus 
induces only low IFN production in epithelial or endothelial cells, APCs and 
especially pDCs produce high levels of IFN-α and TNF-α in response to this virus 
(16, 21, Fig. 4 of III). Since APCs reside in close proximity to the epithelium, APC-
derived pro-inflammatory cytokines may provide cytokine priming to epithelial cells 
also in vivo. It should, however, be noted that the effect of cytokine pre-treatment 
also depends on the stimulus in question. Although TNF-α and/or IFN-α enhance 
the inflammatory cytokine and chemokine production in TLR ligand-stimulated or 
virus-infected epithelial cells, macrophages and dendritic cells (137, 166, 167, and 
IV) the cytokine priming does not enhance the low cytokine and chemokine 
response detected in L. rhamnosus–stimulated mo-DCs (unpublished data). 
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6 CONCLUDING REMARKS 
Macrophages and dendritic cells have an important role in the anti-microbial 
defence. These cells are armed for efficient microbial detection and, upon activation, 
macrophages and DCs produce cytokines and chemokines, which activate innate and 
adaptive immune responses. In this thesis work the ability of pathogenic S. pyogenes
and non-pathogenic L. rhamnosus to activate inflammatory cytokine and chemokine 
gene expression in macrophages and DCs was compared. Differences between cell 
types as well as between pathogenic and non-pathogenic bacteria were observed. 
Bacteria-stimulated macrophages produced similar core set of chemokines in 
response to S. pyogenes and L. rhamnosus. These included CXCL8 and several CC-
chemokines, which enhance the recruitment of monocytes, neutrophils, immature 
DCs and T cells. Thus, macrophages activated by pathogenic or non-pathogenic 
Gram-positive bacteria efficiently enhance the local antimicrobial response by 
promoting the chemotaxis of other effector cells to the site of inflammation. Certain 
differences in the macrophage chemokine response between S. pyogenes and L.
rhamnosus were, however, observed. Only S. pyogenes-stimulated macrophages 
produced inflammatory chemokines CXCL9 and CXCL10, which specifically 
attract Th1 and NK cells. The production of these chemokines and the recruitment of 
NK cells may have a role in enhancing the recognition and destruction of 
intracellular S. pyogenes.
While macrophages were activated by both S. pyogenes and L. rhamnosus, DCs 
showed a clearly distinct response against pathogenic and non-pathogenic bacteria. 
S. pyogenes induced efficient mo-DC maturation accompanied with a strong 
cytokine and chemokine response. S. pyogenes-stimulated mo-DCs produced pro-
inflammatory cytokines, IL-12 family cytokines and Th1 recruiting chemokines 
CXCL9 and CXCL10. S. pyogenes also activated blood primary DCs and the S. 
pyogenes-stimulated blood primary DCs promoted Th1 polarization of naïve CD4+
T cells. Interestingly, S. pyogenes was also found to activate pDCs, which have been 
regarded as “virus-specific” DCs. Thus, S. pyogenes is a very potent activator of 
several human DC types and the human DC system may have more flexibility in the 
antibacterial responses than previously thought. The high potency of S. pyogenes to 
activate several immune cell types and to induce cytokine/chemokine production 
may be both beneficial and harmful for the host. Under normal conditions, rapid 
detection of S. pyogenes and the resulting activation of the immune response is 
likely to efficiently limit the spread of this infection. However, in some cases S.
pyogenes infection may result in uncontrolled and excessive activation of the 
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immune response, which may lead to a severe tissue damage or to the development 
of autoimmune diseases.  
In contrast to S. pyogenes, mo-DCs stimulated with non-pathogenic L. rhamnosus 
showed a “semi-mature” phenotype characterized by up-regulation of co-stimulatory 
markers but low or undetectable cytokine and chemokine production. The induction 
of tolerogenic DCs, which lack inflammatory cytokine response, may provide one 
explanation for the symbiotic coexistence between host and the commensal 
microflora. Moreover, partial but non-inflammatory activation of innate immune 
response may contribute to the suggested immunomodulatory effects of probiotic 
bacteria.  
In conclusion, although macrophages and DCs share several common antimicrobial 
functions the responses against pathogenic and non-pathogenic bacteria were found 
to differ markedly. The results obtained in the present study suggest that tissue 
resident macrophages are efficiently activated by any bacteria, be that pathogenic or 
non-pathogenic. In contrast, DCs may be able to discriminate between pathogenic 
and non-pathogenic bacteria and therefore mount the adaptive immune response 
towards inflammation or tolerance/homeostasis (summarized in Fig. 3). 
Another key question of this thesis work was to analyze the role of pro-
inflammatory cytokines in the regulation of microbe-induced chemokine expression. 
Two key mechanisms were observed. 1) During microbial infection the produced 
pro-inflammatory cytokines were found to directly enhance the expression of certain 
chemokines by increasing transcription factor activation. This was observed in S.
pyogenes-stimulated macrophages, where bacteria-induced production of type I 
IFNs enhanced the production of CXCL9 and CXCL10 chemokines. 2) Another 
important role of pro-inflammatory cytokines in enhancing microbe-induced 
chemokine production was seen in the priming experiments. Pre-treatment of 
epithelial cells with TNF-α or IFN-α significantly enhanced influenza A virus-
induced transcription factor activation and chemokine response. Pro-inflammatory 
cytokines were found to enhance the expression of PRRs and transcription factors, 
thereby rendering epithelial cells for enhanced microbial detection and signal 
transduction. These mechanisms are summarized in Figure 4. 
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Figure 3. Distinct activation of macrophages and DCs in response to pathogenic and 
non-pathogenic Gram-positive bacteria. Both pathogenic Streptococcus 
pyogenes and non-pathogenic Lactobacillus rhamnosus induce the 
production of inflammatory cytokines and chemokines in macrophages. 
This results in the enhancement of local immune response and recruitment 
of effector cells to the site of inflammation. In contrast, DCs may be able to 
discriminate between pathogenic and non-pathogenic bacteria, which results 
in the development of fully mature cytokine-producing DCs (S. pyogenes) or 
semi-mature tolerogenic-like DCs (L. rhamnosus). The differential DC 
maturation may lead to distinct T cell responses supporting inflammation or 
tolerance. 
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Figure 4. Role of pro-inflammatory cytokines in the regulation of microbe-induced 
chemokine production. Microbe detection results in transcription factor 
activation, which leads to the production of pro-inflammatory cytokines 
such as TNF-α and type I IFNs (left cell). Secreted cytokines bind to their 
cell surface receptors, which further activates intracellular signalling. This 
results in enhanced expression of chemokines and other immunoregulatory 
genes during infection. Alternatively, TNF-α and IFN-α may induce the 
expression of PRRs and transcription factors (TFs) in uninfected cells (right 
cell). This renders cells for efficient microbe recognition, intracellular 
signalling and chemokine production upon infection.  
MICROBE TNF-α, IFN-α/β
CHEMOKINES
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MICROBE
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